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ABSTRACT 
Early recognition with appropriate interventions can prevent harm for fetuses suffering 
from hypoxia during labor. Two preliminary studies show that utilizing a relatively 
simple algorithm, created by an expert consensus group in 2013, unambiguously 
identifies fetal heart rate baseline characteristics and deceleration patterns associated 
with risk for dangerous levels of hypoxia/acidemia. This algorithm, designed to help 
clinicians decide if, how, and when to intervene during maternal labor to safely care for 
fetuses who exhibit Category II fetal heart rate tracings during labor, required more 
research to generate more evidence regarding efficacy. The purpose of this study was to 
generate more evidence regarding the efficacy of the algorithm. This study used a 
Donabedian theoretical framework. Public access archived tracings of 552 fetal heart 
rates in the 30-90 minutes preceding delivery were blind analyzed using the Category II 
algorithm decision tree and the associated extensive clarifications for use in algorithm. 
Comparison of the algorithm-driven labor and delivery timing and mode, with the 
actual labor and delivery timing and mode measured outcome differences in newborn 
status, operative vs. non-operative delivery, and timing of delivery. FHR tracings of 175 
out of 177 (98.9%) of the babies born with acidemia (umbilical artery pH <7.20) had 
conservative interventions recommended by algorithm-driven analyses for Category II 
FHR tracings. Earlier delivery at an average of 18.4 minutes (range 5 to 34 minutes) was 
recommended per algorithm-driven analyses for 17 tracings, all of which had birth pH 
<7.20. No increase in operative delivery was recommended for any tracings with pH 
≥7.20. 
Keywords: Category II fetal heart rate tracing algorithm, Donabedian theory 
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CHAPTER 1  
INTRODUCTION 
 Early recognition with appropriate interventions can prevent harm for fetuses 
suffering from hypoxia during labor. Two preliminary studies (Clark et al., 2015; Clark 
et al., 2016) show that utilizing a relatively simple algorithm (Clark et. al., 2013) 
unambiguously identifies fetal heart rate (FHR) baseline characteristics and deceleration 
patterns associated with risk for dangerous levels of fetal hypoxia/acidemia. This 2013 
algorithm was designed to help clinicians decide if, how, and when to intervene during 
maternal labor to safely care for fetuses who exhibit Category II FHR tracings during 
labor. More research was needed to generate more evidence regarding efficacy. The 
purpose of this study was to generate more evidence regarding the efficacy of the 
algorithm.  
Electronic fetal heart rate monitoring in labor is widely employed throughout the 
country. Approximately 89% of U.S. hospital births utilize electronic FHR monitoring 
(Declercq, Sakala, Corry, Applebaum, & Herrlich, 2014). Electronic FHR tracing 
interpretation requires human visual reading of tracings, because current computer 
technology does not integrate a complete clinical picture into automated interpretation. 
Thus, interpretation and management of FHR tracings by nurses and physicians is a 
significant part of intrapartum patient care.   
Electronic FHR monitoring was incorporated into intrapartum clinical practices 
throughout the U.S. without being appropriately validated with scientific evidence 
(Miller, 2012, p.23). In the U.S., standardized electronic FHR terminology has been 
slowly evolving since 1968, when the first commercially available machines became 
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available in this country. Standardized electronic FHR terminology and interpretation 
are important both for patient safety related to meaningful communications between 
clinicians, and for consistency in research protocols. Early electronic FHR research 
results were difficult to compare between studies, due to variation in terminology, 
definitions, and protocols (Association of Women’s Health, Obstetric and Neonatal 
Nurses [AWHONN], 2015, p. 684; National Institute of Child Health and Human 
Development [NICHD], 1997, p.635). As such, the National Institutes of Health and 
Child Development (NICHD) organized workshops for perinatal experts to create 
national standards for electronic FHR monitoring. These workshops took place in 1979, 
1997, and the most recent one in 2008.  
The 1979 workshop summary (Zuspan, Quilligan, Iams, & van Geijn, 1979) 
recommended specific fetal heart rate assessment standards for low-risk and for high-
risk patients in labor using intermittent auscultation and/or continuous electronic fetal 
monitoring methods. It also called for more randomized clinical trials of electronic fetal 
monitoring “coordinated at the national level to provide optimum benefit from the data 
acquired” (p. 1029).  
The 1997 workshop summary (NICHD, 1997) focused on electronic FHR 
monitoring research guidelines for interpretation. The goal of the 1997 workshop was to 
propose a standardized and rigorously “unambiguously described set of definitions 
that can be quantitated” (p. 636). These precise FHR definitions were seen as necessary 
“so that the predictive value of monitoring could be assessed more meaningfully in 
appropriately designed observational studies and clinical trials. Ultimately, this 
research direction should lead to more evidence-based clinical management of 
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intrapartum fetal compromise” (p. 636). Many, but certainly not all, clinicians and L&D 
units began using the NICHD 1997 terminology, since it was mainly intended for 
research purposes. The impetus for a common terminology for daily clinical use largely 
came from The Joint Commission’s 2004 Sentinel Alert #30, which recommended that 
nurses and physicians use standard terminology and participate in FHR interpretation 
education. In a study of 47 cases of perinatal death or permanent disability, 72% of cases 
involved communication issues, and 34% of cases had inadequate fetal monitoring 
involved in root causes (The Joint Commission, 2004). 
The third and most recent NICHD electronic FHR monitoring workshop was to 
update definitions, interpretation, and research guidelines (Macones, Hankins, Spong, 
Hauth, & Moore, 2008a, 2008b).  It will be discussed in detail later in this paper. 
Significantly, in 2006, a U.S. team including three physicians, a nurse, and a 
nurse-midwife concluded from their systematic review, that excluding the occurrence 
of catastrophic events, progressively deepening recurrent late or variable decelerations 
with evolving reduction in fetal heart rate baseline variability “may serve as a trigger 
for action” for attempts to improve fetal oxygen status, since there is usually a relatively 
long period of “approximately one hour” to intervene prior to severe acidemia capable 
of inflicting serious fetal damage (Parer, King, Flanders, Fox, & Kilpatrick, 2006, p. 292). 
They discussed gaps in knowledge and research needs (which support this study’s 
methodology) stating: 
Fetal heart rate monitoring is being used in virtually all delivery suites within 
North America. Interpretations and management decisions are often being made 
in a non-standardized and sometimes subjective way, unsubstantiated by 
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evidence-based observations. Ideally, the relationship between specific FHR 
patterns and fetal acidemia should be determined in a prospectively gathered 
series of unselected cases that includes the full range of different FHR patterns 
recorded up until the time of birth, and measurements of umbilical cord arterial 
blood gases and acid–base state, and other measures of newborn outcome. This 
would enable the determination of the validity of a relationship between specific 
patterns and fetal acidemia. However, in the absence of such a series, we are 
forced to use the observational data that are available. (Parer et al., 2006, p. 292)  
2008 NICHD 3-Tier System for Electronic Fetal Heart Rate Tracing Interpretation 
Tremendous progress in standardizing electronic fetal monitoring clinical 
terminology resulted from national adoption of the 2008 Eunice Kennedy Shriver 
National Institute of Child Health and Human Development (NICHD) 3-tier system of 
FHR tracing definitions and recommended care (Macones et al., 2008a, 2008b). In this 3-
tier classification system, FHR tracings that meet NICHD Category I criteria are 
considered normal and do not require special action, Category II FHR patterns are 
considered indeterminate, requiring continuing re-evaluation, and Category III FHR 
patterns are considered abnormal and require immediate intervention to promptly 
improve fetal oxygenation (Macones et al., 2008a, 2008b) (See Figure 1). It is important 
to note that no NICHD recommendations were in the summary statement to expedite 
delivery, even with a Category III FHR tracing. Also, no recommendations were in the 
summary statement to intervene conservatively or otherwise with a Category II FHR 
tracing. This absence of recommendations was the catalyst for confusion in the obstetric 
community. 
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Figure 1. The 2008 National Institute of Child Health and Human Development 
Workshop Report on Electronic Fetal Monitoring: Update on Definitions, Interpretation, 
and Research Guidelines. (Macones et al., 2008a, p. 514). Copyright 2008 by Elsevier. 
Reprinted under Elsevier open access content user license permission. 
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Category II FHR patterns include many diverse components of fetal heart 
tracings, some which have traditionally been considered benign, and some of which are 
considered very worrisome to many clinicians. Research recommendations included in 
the 2008 NICHD summary stated: “Areas of highest priority for research include 
observational studies focused on indeterminate FHR patterns, including descriptive 
epidemiology, frequency of specific patterns, change over time, the relationship to 
clinically relevant outcomes, and the effect of duration of patterns…” (Macones et al., 
2008a, p. 515, 2008b, p. 665).  
In the current National Institute of Child Health and Human Development 
(NICHD) 3-tier classification system, FHR tracings that meet criteria for NICHD 
Category II FHR patterns are considered indeterminate, requiring continuing bedside 
patient re-evaluation (Macones et al., 2008a, 2008b).  No specific recommendations for when 
and how to intervene when faced with specific types of Category II electronic fetal heart rate 
tracings were described in the 2008 NICHD workshop report.  
 Category II patterns occur in more than 80% of fetuses during labor (Elliott, 
Warrick, Graham, & Hamilton, 2010; Jackson, Holmgren, Esplin, Henry, & Varner, 2011; 
Parer & King, 2010), and the NICHD recommendations are too vague for ensuring safe 
labor and delivery for these fetuses. Category II (indeterminate FHR tracings) data, still 
has not been clearly defined as to interpretation and recommended intervention 
strategies by a national authority. The NICHD 3-tier terminology system (Macones et 
al., 2008a, 2008b) was introduced in September 2008. Universal adoption in the United 
States was endorsed in position statements from professional perinatal organizations 
including the American College of Obstetricians and Gynecologists (American College 
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of Obstetricians and Gynecologists [ACOG], 2009), the Association of Women’s Health, 
Obstetric and Neonatal Nurses (Association of Women’s Health, Obstetric and 
Neonatal Nurses [AWHONN], 2008), and the American College of Nurse Midwives 
(American College of Nurse Midwives [ACNM], 2011). It is notable that national 
universal adoption of the NICHD 3-tier system was accelerated by the simultaneous 
publication of the NICHD Summary Statement in September 2008 in two of the 
country’s most esteemed and popular nursing and medical obstetrics journals (Macones 
et al., 2008a, 2008b). Also, in September 2008, a notification letter was sent to each Nurse 
Manager and to each Medical Director of every Labor/Delivery unit in the U.S., 
regarding the NICHD 3-tier system and terminology/recommendation as the new 
national standard to be instituted for practice and communications by and between all 
obstetrical personnel. 
2009 and 2010 ACOG 3-Tier System Clarifications and Additions to Electronic Fetal 
Heart Rate Tracing Interpretation 
In 2009, the American College of Obstetricians and Gynecologists (ACOG) put 
standards in place by giving direction on nomenclature, interpretation, and intervention 
best practices for Category I and Category III FHR tracings management (covering 
~20% of fetuses). ACOG recommended standards (2009) were adequate for providing 
clear care standards for Category I and Category III FHR tracings. This 2009 ACOG 
Practice Bulletin added an important further intervention to the NICHD list, that of 
delivering the fetus, if conservative measures failed to improve the deteriorating fetus’s 
status: 
Depending on the clinical situation, efforts to expeditiously resolve the abnormal 
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FHR pattern may include but are not limited to provision of maternal oxygen, 
change in maternal position, discontinuation of labor stimulation, treatment of 
maternal hypotension, and treatment of tachysystole with FHR changes. If a 
Category III tracing does not resolve with these measures, delivery should be 
undertaken. (pp. 193-195) 
However, management strategies for Category II FHR tracings, although 
somewhat clearer, were still inadequate: “In some circumstances, either ancillary tests 
to ensure fetal wellbeing or intrauterine resuscitative measures may be used with 
Category II tracings” (ACOG, 2009, p.193). 
In 2010 ACOG published a landmark practice bulletin. This 2010 ACOG Practice 
Bulletin was authored by a collaboration of nationally renowned experts from medicine, 
nursing, and nurse-midwifery, and the results greatly clarified and improved standards 
for decreasing or discontinuing oxytocin in the setting of tachysystole (uterine 
contractions occurring more frequently than 5 in a 10 minute period). Also, this 2010 
ACOG Practice Bulletin defined minimal variability as more than just needing 
continued observation with intrauterine resuscitation/non-operative interventions, 
stating: “Continued minimal variability (in the absence of accelerations or normal scalp 
pH) that cannot be explained or resolved with resuscitation should be considered as 
potentially indicative of fetal acidemia and should be managed accordingly” (p. 1237). 
With Category III FHR tracings, the 2010 ACOG Practice Bulletin stated: “…when a 
decision for operative delivery in the setting of a Category III EFM tracing is made, it 
should be accomplished as expeditiously as feasible” (p. 1237).  
The 2010 ACOG Practice Bulletin also recommended that if a Category II FHR 
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tracing was not improved with intrauterine resuscitative measures, or there is 
progression to a Category III FHR pattern, to consider delivery (See Figure 2). Various 
intrauterine resuscitative measures for Category II or Category III tracings, or both, 
include maternal repositioning, discontinuing uterine stimulants, administering 
maternal uterine relaxants and/or supplemental oxygen and/or IV fluid boluses, 
and/or amnioinfusion if cord compression/variable decelerations are present; and 
elevating the presenting fetal part until operative delivery is carried out if there is an 
umbilical cord prolapse (p. 1236). 
A shortcoming of the ACOG 2010 Practice Bulletin was that it failed to provide 
any time-specific guidance for interventions, although the international literature has 
given time-line recommendations for when to consider minimal variability to be 
pathological for many years (Ayres-de-Campos & Bernardes, 2010; Federation 
International of Gynaecology & Obstetrics [FIGO], 1987; Liston et al., 2007; National 
Institute for Health and Care Excellence [NICE], 2014; NICE, 2007), and good evidence 
exists to justify establishing reasonable time-line standards for intervening for a 
deteriorating fetal status.  
For example, Kamoshita et al. (2010) showed that among 19 patients with 
sustained fetal bradycardia due to umbilical cord prolapse, placental abruption, or 
uterine rupture, when the bradycardia to delivery interval was less than 25 minutes, all 
term pregnancies led to normal neonatal neurologic development at the age of 2 years. 
Leung, Leung, and Paul (1993), reviewed 106 cases of uterine rupture after previous 
cesarean deliver and found that significant neonatal morbidity occurred when ≥ 18 
minutes elapsed between the onset of prolonged deceleration and delivery. King & 
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Parer (2011, p. 670) presented an opinion that a diagnosis of “risk of serious fetal 
acidemia” rather than of “fetal distress” is more precise in their analysis of a case where 
a baby was born vigorous at birth, with Apgar scores of 6 at one minute and 8 at five 
minutes, an umbilical arterial cord gas with a pH of 7.04, and a base excess of -8mEq/L. 
The electronic FHR tracing (See Figure 2) showed absent variability and recurrent late 
decelerations that worsened with conservative measures such as maternal position 
changes and supplemental maternal oxygen administration. An emergency cesarean 
delivery was performed. King and Parer cited this case as a good example of what 
would have been labeled as a “false positive test” of fetal monitoring, because the 
newborn did not have evidence of significant academia. However King and Parer 
maintained that the goal of fetal monitoring is to identify fetuses with an FHR pattern 
that is associated with a significant risk for academia, and to ameliorate the pattern with 
conservative measures, or intervene with earlier delivery if the pattern does not 
improve. As such, they stated that the infant likely “would have had adverse 
consequences of metabolic acidosis if labor had continued without intervention” (p. 
669). In other words, in this case, electronic FHR monitoring worked as devised, to 
screen for a potential problem and to prevent harm by intervening in a timely manner. 
As such, a false positive rate of 100% would be the goal and ideal for Category III FHR 
tracings with fetal monitoring in labor. 
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Figure 2. Category III fetal heart rate tracing (King & Parer, 2011, p.670). Copyright 2011 
by Elsevier. Reprinted with permission. 
 
Attributes of Category II Fetal Heart Rate Tracings  
The NICHD’s 2008 workshop report on electronic fetal monitoring terminology, 
interpretation and research guidelines described Category II FHR tracings as including 
all FHR tracings “not categorized as Category I or Category III. Category II tracings 
may represent an appreciable fraction of those encountered in clinical care” (Macones et 
al., 2008a, p. 514, 2008b, p. 665).  
Dangers associated with prolonged minimal FHR baseline variability were, for 
the most part, ignored by the NICHD 2008 workshop recommendations, even though a 
great deal of evidence showed that persistent minimal base variability was a FHR 
tracing component that commonly occurs in deteriorating fetal status. While many 
healthy fetuses exhibit limited periods of minimal variability, virtually all sick fetuses 
exhibit persistent decreased, minimal variability as they deteriorate and become 
increasingly hypoxic. 
Figure 3 emphasizes the diversity of FHR patterns and components included in 
Category II tracings, some of which are considerably much more worrisome than other 
patterns and components within the table. The components that are of high concern 
have been bolded and underlined. 
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Category II Fetal Heart Rate Tracings Include Any of the Following Examples: 
Baseline Rate Baseline Variability Accelerations Decelerations 
Bradycardia not 
accompanied by 
absent baseline 
variability 
Minimal baseline 
variability 
Recurrent variable 
decelerations 
accompanied by minimal 
or moderate baseline 
variability 
Marked baseline 
variability 
Prolonged deceleration 
>2 minutes but <10 
minutes 
Recurrent late 
decelerations with 
minimal or moderate 
baseline variability 
Tachycardia 
Absent baseline 
variability not 
accompanied by 
recurrent 
decelerations 
Absence of 
induced 
accelerations 
after fetal 
stimulation 
Variable decelerations 
with other characteristics, 
such as slow return to 
baseline, “overshoots,” or 
“shoulders” 
Figure 3. NICHD’s description of Category II fetal heart rate tracings 
(Descriptions adapted from Macones et al., 2008a, p. 514. Copyright 2008 by 
Elsevier. Reprinted under Elsevier open access content user license permission. 
Note: Category II FHR Patterns Occur in Over 80% of All Labors. 
 
Prior to the 2008 National Institute of Child Health and Human Development 
FHR tracing terminology workshop summary (Macones et al., 2008a, 2008b), normal 
tracings were routinely described and documented in the U.S. as “reassuring” FHR 
patterns. In contrast, absent variability in the FHR baseline has long been considered 
pathological, and was commonly described as a “non-reassuring” FHR tracing 
component. More ambiguous is minimal FHR baseline variability, with amplitude 
range from greater-than-undetectable to 5 beats per minute, peak to trough. Minimal 
fetal heart baseline variability may exist for limited periods, usually 20-60 minutes, in 
an adequately oxygenated fetus. In a normal fetus, these limited minimal FHR baseline 
periods are usually due to normal fetal sleep periods or due to maternal administration 
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of narcotics or other medications. Prior to the 2008 NICHD terminology workshop 
summary (Macones et al., 2008ba, 2008b), minimal variability, in some circumstances, 
might have been described as “not reassuring, but not non-reassuring,” which could be 
a confusing issue in the clinical setting. The 2008 NICHD guidelines noticeably did not 
include the terms “reassuring” or “non-reassuring” in the summary statement, instead 
calling Category II tracings “indeterminate,” and stating that all tracings with minimal 
variability should be considered to be Category II tracings (Macones et al., 2008a, 
2008b). 
A fetus may have an FHR tracing which exhibits category changes over time, with or 
without intervention, between NICHD defined categories. As a fetus becomes stressed 
or hypoxic, compensatory changes (Ugwumadu, 2014) may be demonstrated with FHR 
patterns, which may include baseline variability initially becoming marked, or 
decreasing; variable or late decelerations of the FHR, and/or increases or decreases in 
baseline rate. Applying Ugwumadu’s 2014 physiologic model to the NICHD’s 3-tier 
system (See Figure 5), Category II tracings would indicate fetal compensatory responses 
to stress or oxygen deprivation. Category III tracings are somewhat analogous to the 
Society of Obstetricians and Gynaecologists of Canada (SOGC), and to the British 
National Institute for Health and Care Excellence (NICE) and to the European 
International Federation of Gynecology and Obstetrics (FIGO) electronic fetal 
monitoring tracing interpretations of abnormal or pathological patterns (NICE, 2014 & 
2007; Ayers Campos & Bernardes, 2010; Liston, Sawchuck, & Young 2007). However, 
the U.S. NICHD 3-tier system includes minimal baseline variability of detectable-but-
less-than-5 beats per minute as a Category II FHR tracing component, whereas the 
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SOGC, NICE and FIGO guidelines consider more than 40 to 80-90 minutes of minimal 
FHR baseline variability to be abnormal or pathological (Figure 4).  
Moderate FHR baseline variability is associated with fetal blood pH >7.0. Fetal 
injury or death due to oxygen deprivation does not result unless the fetus 
decompensates with significant fetal metabolic acidemia with a pH less than 7.0 and a 
base deficit ≥12 mmol/L (ACOG, 2014; Miller, 2011).  This means that clinicians usually 
have time to intervene with supportive care for a decompensating fetus in labor, when a 
Category I tracing changes to one with minimal or absent variability with significant 
FHR decelerations, if fetal monitoring is interpreted and actions taken in a standardized 
method (except with an extremely rare catastrophe, such as very rapid fetal 
exsanguination from a ruptured vasa previa, umbilical cord prolapse, etc. occur). 
 
Figure 4: Physiologic Electronic Fetal Heart Rate Tracing Interpretation 
In a September 2016 editorial, Vintzileos & Smulian wrote that “most fetuses are 
• Normal Acid-Base Status 
• Must include: moderate 
variability, 110-160 
baseline rate, +/- early 
decelerations, +/- 
accelerations 
Category I - 
Normal 
• Any other fetal heart rate 
characteristics that are not 
category I or category III 
Category II 
Compensating Fetus • Decompensating Fetus with Abnormal Acid-Base Status 
• Absent variability with recurrent 
late or variable decelerations or 
bradycardia 
• Sinusoidal pattern 
• (Canadian, UK & European 
standards include minimal 
variability >40-90 minutes in this 
category) 
Category III - 
Abnormal 
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developing acidemia when their FHR tracing is still Category II… when fetuses 
progress from adaption to deterioration. In the absence of a correctable etiology, this 
may be the most appropriate time for a delivery intervention” (p. 263). 
Much literature has focused on clarifying how to use the 2008 NICHD 3-tier 
system for effectively interpreting and managing the broad spectrum of ambiguous 
FHR patterns of Category II tracings (ACOG, 2009, 2010; Hamilton, Warrick, & 
O’Keeffe, 2012; King & Parer, 2011; Parer & King, 2010). Even when the ACOG 
electronic FHR practice bulletins were updated (ACOG 2009, 2010), adequate clarity 
was achieved for Category I and Category III tracings, yet there were still no clear 
timelines or comprehensive standards for managing Category II tracings. U.S. nurses 
and physicians lack a clear nationally sanctioned standard of care for the 80% of fetuses 
demonstrating Category II FHR tracings during the intrapartum period. Whereas 
Canadian, British, and European professional obstetric standards give variable but 
clearer guidance as to the maximum length of time absence of moderate variability in 
the FHR baseline should be observed before obstetric intervention is recommended (a 
Category II FHR classification in the U.S.), American nurses and physicians continue to 
have no national level sanctioned guidance on this issue. Consequences include a lack 
of improvement in U.S. neonatal mortality rates and high U.S. cesarean rates compared 
to other nations (See Table 1).  
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Table 1. Mortality rate, neonatal (per 1,000 live births)a  -Cesarean rate (per 1,000 live births)b  
Country 1990 Neonatal 
Mortality Rate
a 
2015 Neonatal 
Mortality Rate
a 
2013 
Cesarean Rate
b 
Finland 4 1 158.0 
Luxembourg 4 1 270.2 
Israel 6 2 158.3 
Sweden 4 2 164.2 
Austria 5 2 287.8 
Czech 10 2 248.7 
Cuba 7 2 356 (2005 WHO data)d 
Greece 10 3 169 (2006 WHO data)d 
Italy  9.7 (UN)
e 3 361.4 
USA 6 4 327
c 
a Source World Bank (2016) 
b Source Organisation for Economic Co-operation and Development (2016)  
c Source Osterman & Martin (2014)  
d Source World Health Organization (WHO) (2010)  
e Source United Nations (UN) (2016)  
 
Rescue during Category III FHR tracings, which are predictive of abnormal fetal 
acid-base status at the time of observation, may be too late to prevent permanent fetal 
injury or death. Conservative preventative measures before deterioration from a 
concerning Category II to a Category III FHR tracing may improve fetal outcomes while 
preventing some otherwise unnecessary cesarean or operative vaginal deliveries. If 
maternal position changes, maternal supplemental oxygen administration, uterine 
contraction suppression, or improving maternal blood pressure/placental blood flow, 
etc., fail to improve the FHR pattern, then earlier delivery may mitigate or prevent fetal 
harm. 
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The consensus group’s algorithm (Clark et al., 2013) explains Category II FHR 
tracings in unambiguous, time-specific terms related to labor stage and progress. It 
specifies very clear timing for recommended observations and interventions that 
remain within the current ambiguous national standard of care while offering an option 
for improved patient safety and standardized professional care. According to Clark et 
al. (2013): 
… our algorithm does not seek to replace any established methodical approach 
to the management of Category II patterns. Rather, we suggest that this 
algorithm will be helpful in the current clinical setting in the United States in 
which a lack of clear direction has led to divergent decision making regarding 
cesarean section for FHR abnormalities… Application of the algorithm, along 
with the integration of future evidence-based modifications driven by additional 
research, will provide clinicians with a standardized, simple, rational, evidence-
based, and nationally accepted approach to the management of Category II FHR 
patterns. (p. 96) 
The Clark et al., 2013 group’s algorithm helps nurses and physicians to 
unambiguously identify FHR baseline characteristics and deceleration patterns 
associated with risk for dangerous levels of hypoxia/acidemia. Early identification 
allows enough time to safely use conservative methods to improve the FHR patterns. If 
conservative methods do not ameliorate the FHR patterns then the option would be to 
deliver the fetus well before those levels of hypoxia/acidemia are reached, rather than 
waiting until the fetus is dangerously hypoxic/acidotic, then making the decision to 
deliver.  
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In the Clark group’s 2013 article, which lays out the new algorithm and 
recommendations for standards of care for Category II fetal heart rate tracing 
interpretation and intervention strategies, the healthcare community is requested to test 
this algorithm and report on its level of efficacy. It is crucial to understand that 
standardization does not means throwing away professional judgment and trying to 
make the situation fit the standard, but rather standardization is a place and a structure 
from which to start, helping to lessen the possibility of preventable error through 
reminders, decision flow charts, and common courses of action, to cross-check and 
document all of the steps necessary for optimal outcomes. An example from another 
profession, are the standard checklists, protocols, and nomenclature used by pilots for 
tasks such as pre-flight, instrument checks, engine-on, take-off, level flight, landing, 
communication, and the mandatory training of pilots in a large number of emergency 
procedures. This training makes pilots able to handle common situations and 
emergencies almost reflexively, and makes unusual situations easier to deal with 
because of the comprehensive knowledge of their profession they already hold through 
this extensive training. An example of an airline pilot who exemplified this standard, is 
Chesley Sullenberger. He landed his airliner in the Hudson River in 2009, after both 
engines were disabled by a flight of Canada geese hitting the engines. Obviously, this 
particular problem is not exactly part of pilot training. However, because of his 
extensive training in emergency procedures, he and his crew were able to safely land 
the airliner in the Hudson River, without a single passenger or flight crew casualty. 
This same idea holds true for the standardization of intrapartum fetal heart rate 
monitoring management. Training in how to react appropriately in all of the situations 
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that can be anticipated, emergency and otherwise, only makes the medical professional 
more competent in handling the unusual. 
Healthcare is not a static activity – changes in disorders, technologies, treatments, 
and environmental factors constantly change.  Nurses and physicians are not above or 
exempt from the need to constantly retrain and adhere to regularly updated 
standardized care protocols anymore than airline pilots or other professionals.  In the 
field of obstetrics, nurses, nurse-midwives, obstetricians, and perinatologists need 
certification and regularly scheduled recertification in electronic fetal monitoring to 
keep up with skills, changes, and innovations in fetal heart rate tracing interpretation 
and patient care management. 
Purpose of the Study 
The purpose of this study was to test the Algorithm for Management of Category II 
Fetal Heart Rate Tracings, created by Clark et al. (2013), to generate more evidence to 
evaluate its utility for improved efficacy in the interpretation and clinical management 
of Category II FHR tracings. This study blind tested the Clark et al., 2013 Category II 
FHR monitoring algorithm on 552 FHR tracings (Chudáˇcek et al., 2014) retrospectively, 
without reference to the original decisions made and interventions carried out at the 
time each strip was made. The 2013 algorithm decision tree and associated extensive 
“clarifications for use in algorithm,” were thus tested to see if its use gave unambiguous 
direction on interpretation and intervention for these 552 FHR tracings, which would 
potentially yield better fetal (higher Apgar scores, less acidosis, fewer admissions to NICU, less 
neurological and other damage, etc.) outcomes, as it has in the two Clark et al. 2015 and 2016 
research efforts. 
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Research Question 1. Will Clark et al.’s (2013) Algorithm for Management of 
Category II Fetal Heart Rate Tracings reliably give unambiguous direction on 
interpretation and intervention for Category II fetal heart rate tracings? 
Research Question 2. Can using the Clark et al.’s (2013) Algorithm for 
Management of Category II Fetal Heart Rate Tracings on the 552 fetal heart rate and uterine 
contraction tracings result in different recommendations for management and 
intervention forecasting a possibly improved outcome over the actual result? 
Significance of the Study 
 This study is significant because more research was needed to validate the Clark 
et al., 2013 Category II FHR tracing algorithm and the associated standards of care labor 
management recommendations for national use, since at this point in time, only two 
research efforts have been carried out with this in mind (Clark et al., 2015, 2016). This 
study was necessary since more research evidence was required to validate the efficacy 
of the 2013 algorithm. Currently there is no nationally recognized method available 
from which to develop a clear national standard for the unambiguous interpretation 
and intervention of Category II FHR tracings. The NICHD and ACOG put in place clear 
standards for the 20% of fetuses who have tracings that fall solely into Categories I 
(normal) and III (abnormal), but left fetuses who have Category II tracings, which make 
up at least 80% of the total fetuses, with FHR tracings classified as indeterminate. This is 
an ambiguous classification of fetuses with Category II heart rate tracings, which can 
deteriorate and enter the Category III classification, or improve and enter Category I.  
The Clark group’s unambiguous Category II FHR tracing algorithm is a 
combination of a fetal intervention decision tree and a set of recommendations 
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(extensive “clarifications for use in algorithm”) for standardizing care based on the fetal 
status and labor progress. Since further research efforts are necessary to provide proof 
that the algorithm works or does not work as posited in various clinical settings, this 
study helped further this process. Efforts to construct clear national standards, covering 
electronic FHR tracings of Category I, Category II, and Category III, are sorely needed; 
to facilitate various types and categories of FHR tracings to be read and interpreted 
intelligently, so that when interventions were indicated, they can be initiated in a timely 
manner, so as to yield optimum fetal and maternal outcomes. Goals should be set to 
achieve significantly better newborn Apgar scores, fewer NICU admissions, fewer fetal 
neurological problems, and fewer fetal deaths; as well as lower rates of cesarean and 
operative deliveries, and increased rates of spontaneous vaginal births. 
Of secondary interest, this study was the first to use the 2013 Category II 
algorithm on electronic FHR tracings from outside the United States. This tested the 
algorithm to see if it was applicable in the international community, rather than only 
usable on FHR tracings generated in U.S. obstetrical settings. 
Theoretical Framework 
 The theoretical framework chosen for use in this research study was the 
Donabedian Model. According to Donabedian (2003), how well a health care system 
functions, is controlled by structure, process, and outcome. Structure is how “a health 
care system is set up” (p. 50). Process means “quality of the process of care” (p. 52). 
Outcome is defined “as the consequences attributable to antecedent care” (p. 52). The 
relationship of these three attributes is bi-directional, but cyclical, with a feedback loop. 
Donabedian states that his concept of “planned reconnaissance” (p. 31) involves 
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constant monitoring for problems, which involves the process of changing how a health 
care system functions, if a problem is identified (See Figure 5). 
 
Figure 5: Donabedian (2003) Framework Applied To Category II FHR  
Tracings Interpretation And Intervention Problem 
 
The structure of the U.S. obstetrics health care system has a problem. The process 
of caring for fetuses displaying Category II FHR tracings is the problem, since there is 
no evidence-based national standard for unambiguously interpreting and intervening 
appropriately under such conditions. The outcome is that fetuses displaying Category II 
FHR tracings may be given inconsistent care yielding less than optimal outcomes. The 
problem, at that point, is defined: Produce an evidence-based standard for 
unambiguously interpreting and intervening when fetuses display worrisome Category 
II FHR tracings.  
Troubleshooting, is described by Donabedian (2003), as denoting “action in 
response to a clear problem by someone qualified to solve it” (p 30-31). In the case of 
Structure 
(How Healthcare is Set up, Personnel, & Equipment) 
Electronic fetal monitors in widespread use. Ambiguous national standards for 
fetal heart rate tracing interpretation & management guidelines 
Process 
(Diagnosis, Treatment, 
Prevention) 
Wide variation between clinicians 
for interpretating fetal heart rate 
tracings and managing patients 
with Category II tracings 
Outcome 
(Desirable or Undesirable Changes in 
Individuals & Populations Attributed 
to Health Care) 
U.S. infant morbidity and mortality rates 
associated with intrapartum managment 
remain suboptimal 
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Category II FHR tracings, the clear problem is the inability of current NICHD 
terminology or fetal monitoring guidelines from U.S. medical and nursing professional 
organizations to give unambiguous interpretation and intervention direction for fetuses 
displaying Category II FHR tracings. The troubleshooting needed was for some entity 
to ascertain beneficial techniques and publish them, so that they might be disseminated 
among the U.S. obstetrical research and clinical community, and tested for efficacy and 
reliability. The “someone qualified to solve it” was the eighteen-member expert group 
who developed and published the Clark et al., 2013 algorithm, and the associated 
clarifications for use in algorithm. The Clark et al, 2013 consensus group was composed 
of representatives of the most experienced and most highly qualified national leaders in 
U.S. medical, nursing, and nurse-midwifery intrapartum specialties. Table 2 
demonstrates the vast number of times these perinatal experts have been cited by others 
in the literature, regarding this groups’ immense quantity of peer-reviewed 
publications. 
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Table 2. Author Information for Intrapartum management of Category II fetal heart rate tracings: 
towards standardization of care Clark et al., 2013) 
Author Current Affiliation Academic 
Publications per 
Web of Science 
Number of times 
Cited by others per 
Web of Science 
Steven L. Clark, MD
  
Hospital Corporation of America 189 publications cited by others 4044 
Michael P. Nageotte, 
MD 
Long Beach Mem Hospital, Long 
Beach, CA 
93 publications cited by others 1659 
Thomas J. Garite, MD University of California, Irvine 148 publications  cited by others 3885 
ad Roger K. Freeman, 
MD 
University of California, Irvine 68 publications cited by others 2082 
d David A. Miller, MD
  
University of Southern California, 
L.A. 
84 publications cited by others 1575 
d Kathleen R. 
Simpson, RN, PhD 
Mercy Hospital, St. Louis, MO 114 publications cited by others 443 
Michael A. Belfort, 
MD, PhD 
Baylor College of Medicine & 
Texas Children’s Hospital 
155 publications cited by others 1859 
Gary A. Dildy, MD Baylor College of Medicine & 
Texas Children’s Hospital 
118 publications cited by others 2037 
abcd Julian T. Parer, 
MD, PhD 
University of California, San 
Francisco 
99 publications cited by others 1959 
Richard L. Berkowitz, 
MD 
Presbyterian/Columbia 
University, New York 
201 publications cited by others 6335 
d Mary D’Alton, MD Presbyterian/Columbia 
University, New York 
88 publications cited by others 708 
Dwight J. Rouse, MD Brown University and Women & 
Infant’s Hospital, RI 
252 publications cited by others 3363 
Larry C. Gilstrap, MD University of Texas, Houston  129 publications cited by others 3368 
b Anthony M. 
Vintzileos, MD 
Winthrop University Hospital, 
Mineola, NY 
295 publications cited by others 6647 
J. Peter van Dorsten, 
MD 
Medical University of South 
Carolina, Charleston, SC 
25 publications cited by others 273 
b Frank H. Boehm, 
MD 
Vanderbilt University, Nashville, 
TN 
54 publications cited by others 1059 
Lisa A. Miller, CNM, 
JD 
Perinatal Risk Managment & 
Consultation, Portland, OR 
76 publications cited by others 209 
d Gary D. V. Hankins, 
MD 
University of Texas Medical 
Branch, Galveston 
38 publications cited by others 346 
Table data retrieved on August 20, 2016 from 
http://apps.webofknowledge.com.eres.library.manoa.hawaii.edu/WOS_GeneralSearch_input.do?product=
WOS&SID=1EFOgmxIlLAYeo53kw4&search_mode=GeneralSearch 
Note: This list does not include the many authored textbooks and textbook chapters, professional 
association contributions to protocols and recommendations, years of contributions as presenters 
at local and national obstetrics conferences, and years of teaching to medical, nursing, and 
nurse-midwifery students in clinical and research venues. 
a Participated in 2008 NIH Electronic Fetal Heart Rate Tracing Terminology Workshop 
b Participated in 1997 NIH Electronic Fetal Heart Rate Tracing Terminology Workshop 
c Chair, 1997 NIH Electronic Fetal Heart Rate Tracing Terminology Workshop 
d Participated in 1979 NIH Electronic Fetal Heart Rate Tracing Terminology Workshop 
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This Donabedian (2003) Structure Process Outcome Model based study is 
designed to put forward evidence to further test the Clark et al. (2013) algorithm so as 
to alleviate the previously mentioned structural problem in the U.S. obstetrical health 
care system. This would change an important part of the obstetric management of care 
process by which fetal Category II heart rate tracings are interpreted and conditions 
under which intervention and types of interventions are carried out, possibly yielding 
improved outcomes for fetuses displaying Category II FHR tracings. 
Implications for Research and Knowledge Development 
 Since, at this point in time, there have been only two published clinical research 
efforts to evaluate the efficacy of the Clark et al., 2013 Category II interpretation and 
management algorithm (Clark et al., 2015, 2016), there are many opportunities for 
research efforts around the world to further test and improve the efficacy of this 
unambiguous Category II FHR tracings interpretation and intervention algorithm. 
Some of these efforts could be international, so as to take advantage of the different 
Category I, II, and III standards that exist outside of the United States that could be 
melded into this algorithm and vice versa, to our mutual benefit.  
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Initial Literature Search 
A literature to investigate the response to Category II FHR tracing definitions 
and recommendations from the 2008 NICHD’s introduction of the 3-tier system was 
carried out. Medline, Google Scholar, ProQuest, Science Direct, and Academic Search 
Complete were searched to find peer-reviewed articles, which related to improving 
Category II FHR tracing interpretation and management. The reference lists and any 
sources in the “cited by” areas of the included articles’ online sources were also 
searched. Search parameters included being written in English and published in 
academic journals between September, 2008 and August, 2013. Search keywords 
included: Category II FHR management, Category 2 fetal heart rate tracing, and 
electronic fetal heart rate monitoring standards of care.  
During this first search, the Algorithm for Management of Category II Fetal Heart 
Rate Tracings (Clark et al., 2013) was identified as the basis for this ongoing research 
effort. Additional literature was identified dating from September, 2008 to August, 
2013, which provided material showing the research progress which made possible the 
creation of the important break-through developed and written up by Steven Clark and 
his colleagues, and which was published in August, 2013. 
Inclusion criteria. Initially, articles that discussed application of the 2008 NICHD 
3-tier system fetal heart rate tracing interpretation or management recommendations 
were included. This search produced 95 articles. To focus on Category II issues of 
interpretation and management strategies, only articles, which gave new strategies or 
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examples of Category II definitions or management recommendations, were included. 
While each included article had to contain novel concepts concerning Category II fetal 
heart rate tracing interpretation or management, the novel concept, information, or 
example did not have to originate with that article; it could contain secondary sources 
for explaining the new concept.  This decreased the number of articles for the initial 
literature search to three, including the Clark et al., 2013 algorithm article, for the initial 
literature search. 
Exclusion criteria. Those articles, which did not discuss, use, or reference the 
2008 NICHD 3-tier system of fetal heart rate tracing interpretation or management 
criteria or recommendations, and further, did not contain novel solutions to the 
Category II fetal heart rate tracings interpretation, management, and intervention 
problem were excluded. 
The Second Focused Literature Review 
To investigate the response to and level of adoption in the field, of the Algorithm 
for Management of Category II Fetal Heart Rate Tracings (Clark et al., 2013), a second, more 
focused literature search was undertaken. Medline, Google Scholar, ProQuest, Science 
Direct, and Academic Search Complete were searched to find peer-reviewed articles, 
which either discussed or referenced the above algorithm and/or the associated article. 
The reference lists and any sources in the “cited by” areas of the included articles’ 
online sources were also searched. Search parameters included, articles written in 
English and published in academic journals, between August, 2013 to April, 2016. 
Search keywords included: Category II fetal heart rate management algorithm, 
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Category II fetal heart rate tracing management algorithm, Category 2 fetal heart rate 
tracing, and electronic fetal heart rate monitoring standards of care. 
Inclusion criteria.  Only articles, which discussed the adoption of, or research to 
test, the Clark, et al., 2013 algorithm’s efficacy were considered. This search produced 
22 articles, from which seven articles were selected as most relevant, for a total, 
including those three articles from the initial search, of ten total articles. 
Exclusion criteria.  Those articles, which did not discuss, use, or reference the 
Intrapartum Management Of Category II Fetal Heart Rate Tracings: Towards 
Standardization Of Care  (Clark et al., 2013) or the associated fetal heart rate tracings 
algorithm, were excluded. Because of the specificity of the search criteria as to the 
above-mentioned algorithm and article, and the associated date of 2013 or newer, all 
seven articles picked for in-depth review were published in 2013, 2014, 2015, or 2016. 
Findings 
 The first and most important article, the Intrapartum Management Of Category II 
Fetal Heart Rate Tracings: Towards Standardization Of Care (Clark et al., 2013), was the 
focus of this literature search and research effort, and the basis against which to 
evaluate the other nine papers. In addition, the importance of the fetal heart rate 
tracings algorithm, explained in the 2013 Clark et al. paper, and the associated 
recommended standards of care cannot be overemphasized as a tool to clarify and 
improve the management of the more than 80% of fetuses who have heart rate tracings 
that come under Category II classification.  
 In 2013, eighteen national experts from medicine, nursing, and nurse-midwifery 
came together with a goal to put together a Category II FHR tracings algorithm, a 
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combination of a FHR tracings interpretation and intervention decision tree and a set of 
recommendations for an associated standard of care based on the algorithm. The reason 
for this activity was the fact that there had never been a straightforward national 
standard for the management of Category II FHR tracings patterns, despite the fact that 
Category II patterns occur in over 80% of fetuses during labor. The basis of this 
algorithm was the synthesis of the knowledge of these 18 experts, using the best 
currently existing science and the best available evidence-based research in the field of 
FHR tracings interpretation and intervention, as well as their varied and wide 
experience. This model was assembled and published by this group, to be tested by 
other healthcare professionals in the field of obstetrics, so that the model could be 
verified, and recommendations for improvement, standardization, and general 
adoption could be made. The standards for Category II FHR tracings interpretation and 
intervention, up to this point, had been relatively vague and inadequate. The final 
sentence from the article, provided the rationale for this paper, as well as providing 
justification for further research on this topic: “Application of the algorithm, along with 
the integration of future evidence-based modifications driven by additional research, 
will provide clinicians with a standardized, simple, rational, evidence-based, and 
nationally accepted approach to the management of Category II FHR patterns” (Clark et 
al., 2013, p. 96). 
It is noteworthy that six of those in this group of eighteen were past participants 
of the 2008 NICHD FHR tracing terminology 43-member U.S./Canadian/UK workshop 
(Macones et al., 2008a, 2008b), and two others in the group had participated in either the 
1997 U.S./Canadian/UK (NICHD, 1997) or in the 1979 U.S./Canadian/UK (Zuspan, 
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Quilligan, Iams, & van Geijn, 1979) NICHD electronic fetal monitoring terminology 
consensus workgroups. One member of the Clark et al. 2013 group participated in all 
three workgroups, including chairing the 1997 workgroup. All eighteen participants 
had published multiple works on electronic fetal monitoring in peer-reviewed journals 
and most had been authors, editors, or contributors for numerous medical or nursing 
textbooks on electronic fetal monitoring and/or obstetrics. The Clark et al., 2013 
consensus group was composed of representatives of the most experienced and most 
highly qualified national leaders in U.S. medical, nursing, and nurse-midwifery 
intrapartum specialties. 
The Clark et al., 2013 Category II FHR tracing algorithm is a combination of a 
fetal intervention decision tree and a set of recommendations for standardizing care 
based on the fetal status and labor progress. The decision tree starts with Category II 
FHR tracings, which do or do not exhibit moderate variability or accelerations. A major 
difference from the NICHD 3-tier system is that in the algorithm by Clark et al. (2013), 
minimal FHR baseline variability is managed the same as absent variability (Druzin & 
Peterson, 2014). Also, the 2008 NICHD definitions combined all variable decelerations 
that were not recurrent (occurring with less than 50% of the uterine contractions) and 
accompanied by absent baseline FHR variability, as Category II patterns. Instead, the 
Category II algorithm subcategorizes all late or prolonged decelerations, as well as 
variable decelerations lasting more than 60 seconds with nadir less than 60 beats per 
minute or less than 60 beats per minute below the baseline, into “significant 
decelerations” (Clark et al., 2013). This Category II algorithm by Clark et al., (2013), uses 
several time-dependent decision steps to arrive at several possible actions: Manage Per 
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Algorithm, Observe, Cesarean or Operative Vaginal Delivery, or Cesarean Delivery. 
The algorithm proposed by Clark et al. (2013), for patient care of Category II fetal heart 
tracings gives more specific interpretation and management recommendations (See 
Figure 6 and Appendix).  
 
 
Figure 6: The Algorithm for Management of Category II Fetal Heart Rate Tracings 
(Clark et al., 2013). Copyright 2013 by Elsevier. Reprinted with permission. 
 
 The second paper is authored by Simpson (2014a), Labor Management Evidence 
Update - Potential to Minimize Risk of Cesarean Birth in Healthy Women. Simpson discusses 
the Category II FHR tracings algorithm, speculating that using the algorithm would 
help in lowering the current 32.8 per 100 birth rate of cesarean births in the United 
States, which Simpson says is both dangerous and unnecessary. Simpson explains that 
OVG, operative vaginal delivery
 
a
That have not resolved with appropriate conservative corrective measures, which may include supplemental oxygen, maternal position changes, 
intravenous fluid administration, correction of hypotension, reduction or discontinuation of uterine stimulation, administration of uterine relaxant, 
amnioinfusion, and/or changes in second stage breathing and pushing techniques. 
Clark. Category II FHRT. Am J Obstet Gynecol 2013. 
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the high cesarean rate has come about because the maternal birthing population is both 
older and has a noticeably higher BMI, and induction of labor is much more prevalent. 
Simpson also notes in comparing women in spontaneous labor, with a single vertex 
baby, an increase of +2.6 hours in first-stage labors compared to 50 years ago. This 
article also points out that the most common reason for cesarean birth (up to 50%) is 
labor dystocia/failure to progress/cephalopelvic disproportion. Interestingly, Simpson 
states that many women are never actually in labor when this diagnosis is made. 
Instead, they are generally diagnosed before they even go into active labor, since recent 
data suggest active labor more likely begins at 6 cm, vs. the traditionally accepted 4 cm 
dilatation. Thus, many women really haven’t been given enough time to progress 
during a labor induction/augmentation. The paper then goes on to explain the dangers 
of cesarean section vs. vaginal delivery, particularly the heightened dangers of repeat 
cesarean sections. Simpson also states that cesarean section has all of the dangers of 
major surgery, and should not be done, unless there are immediate and compelling 
reasons to do so. Simpson does not mention fear of malpractice as one of the reasons for 
cesarean section, although she mentions that the care provider income from cesarean 
section is double that of vaginal birth. The main focus of Simpson’s paper is advocating 
the use of the Category II FHR tracings algorithm as a way to avoid cesarean section, 
except when medically necessary. Simpson explains that by using the algorithm, longer 
birthing times at all stages can be more safely done, and the goal of a successful vaginal 
birth with a normal, viable baby can be reached more often. Simpson stresses the 
importance of being knowledgeable of updated evidence, of being well-versed 
regarding improvements in safe labor management, and of being aware that “patience 
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is underrated as a patient safety strategy” (Simpson, 2014a, p 115). 
The third paper reviewed is Managing an Indeterminate (Category II) Fetal Heart 
Rate Tracing During Labor (Simpson, 2014b). Simpson summarizes the main points of the 
Clark group’s 2013 article. In this summary, Simpson points out that identifying FHR 
tracings as Category II, has limited value since Category II FHR tracings cover a large 
range of physiological characteristics which have varying levels of concern, depending 
on how far along a mother is in labor and how stable the status of fetus. Simpson then 
explains how the new 2013 Category II FHR algorithm can give the healthcare 
professional tools to overcome the seeming indeterminate nature of Category II FHR 
tracings through the use of the Category II FHR tracings decision tree and the 
associated management standards of care. Using these two tools, gives the healthcare 
professional guidance on when to: observe, manage per the algorithm (i.e. intervene to 
take steps to correct a developing problem), or initiate steps to expedite birth of the 
fetus quickly by cesarean or operative vaginal delivery (OVD). The basic goal is to 
resolve problems as they arise, before they become serious, so that normal labor 
continues, resulting in a spontaneous vaginal birth of a vigorous, healthy, baby; or if 
necessary, to intervene in a timely fashion and deliver the fetus by cesarean or operative 
vaginal delivery, to result in the birth of a vigorous, healthy, baby. 
 The fourth article, an electronic fetal monitoring case review by Druzin and 
Peterson (2014), discusses the 2013 Clark et al. article and algorithm. Druzin and 
Peterson contrast the major differences in intervention strategies between the National 
Institute of Child Health and Human Development recommendations, and those 
described in the Clark, et al., 2013 article. Druzin and Peterson note that in the Clark 
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group’s algorithm: “moderate variability and/or accelerations are required to diagnose 
a nonacidotic fetus. The distinction between minimal and absent variability becomes 
irrelevant” (p. e255). The basic idea is that looking for signs of a nonacidotic fetus who 
is not in trouble, is key to deciding on routine management or observation. Conversely, 
looking for signs that the visibly decompensating fetus is in deadly trouble is wasting 
precious time. 
Druzin and Peterson’s (2014) case study involves a mother at 39 2/7 weeks 
gestation, admitted to Labor & Delivery, requesting a repeat cesarean, with a 24 hour 
history of decreased fetal movement. It is probable that had the 2013 algorithm been 
used when this patient’s initial fetal heart pattern showed a Category II tracing of 
minimal baseline variability with recurrent late decelerations, that delivery would have 
been expedited, occurring more than 2 hours sooner. While sooner delivery would not 
necessarily have brought a normal outcome, it probably would have made for an 
improved outcome for this newborn. The Apgar scores were 1, 1, 6, & 8 at 1, 5, 10 & 15 
minutes respectively, and there was a neonatal hemoglobin level of 3 g/dL (normal 
newborn level = 19.3+2.2 g/dL). Druzin and Peterson’s incisiveness in noting the key 
advances inherent in the new algorithm in interpretation and hence timely intervention 
as it concerned this case study, demonstrates how on a case-by-case basis, this new 
technique is winning credibility among those astute enough to understand and realize 
the power of its application. 
The fifth article, Standardization of Intrapartum Management and Impact on Adverse 
Outcomes (Pettker, 2011), discusses improved patient outcomes from applying 
protocols, guidelines, and checklists, and praises the Minkoff & Berkowitz (2009) 
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concept of the FHR monitoring “bundle” of checklists/organized activities. Pettker 
(2011) suggests that electronic health records might be enabled with computerized 
warning flags or pop-ups generated in real-time when abnormal FHR tracing 
components are documented. Futhermore, Pettker’s (2011) description of a 
standardized labor progress note from Yale-New Haven Hospital is somewhat akin to a 
concept of forcing providers to more completely and accurately describe electronic FHR 
tracings by hardstops in the electronic health record that require completion of at least 5 
critical FHR assessment components: “baseline, variability, accelerations, decelerations, 
and Category” (p. 3). 
The sixth paper, by Flood Chez and McMurtry Baird (2011), Electronic Fetal Heart 
Rate Monitoring: Where Are We Now? gives a history of past and current controversies 
and challenges related to intrapartum evaluation and management of fetal heart rate 
tracings. The authors point out that the 2004 Joint Commission Sentinel Event Alert No. 
30: Preventing Infant Death and Injury during Delivery and The Joint Commission (2004) 
recommendation for institutions to follow the American Academy of Pediatrics and the 
American College of Obstetricians and Gynecologists advice to: “a. Develop clear 
guidelines … including nursing protocols for the interpretation of FHR tracings. b. 
Educate nurses, residents, nurse midwives, and physicians to use standardized 
terminology to communicate abnormal FHR tracings,“ (American Academy of Pediatrics 
& American College of Obstetricians and Gynecologists, 2002, pp. 127, 133-134). Flood Chez 
and McMurtry Baird (2011) summarize the frustrations of more than 30 years of the 
obstetric community to clearly define and classify electronic fetal monitoring 
parameters – which has resulted in the continuing interobserver variability in 
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interpretation and management of various FHR patterns. The authors also gave an 
explanation of Parer and Ikeda’s 2007 five-tier system of 134 identified FHR patterns, 
color-coded from green (no threat of acidemia), blue-yellow-orange (3 intermediate 
categories corresponding to NICHD Category II), and red (severe threat of acidemia). 
This inclusion of Parer and Ikeda’s 2007 5-tier system is significant since numerous U.S. 
and Japanese facilities, textbooks, researchers and others use or refer to the 5-tier 
system. 
The seventh published writing which quotes a portion of the Clark et al., 2013 
article, is the April, 2015 ACOG Committee Opinion number 629, Clinical Guidelines and 
Standardization of Practice to Improve Outcomes. The quoted text is as follows:  
The adoption by the clinical care team of one appropriate specific 
management plan will, by virtue of standardization alone, yield results 
superior to those achieved by random application of several individually 
equivalent approaches. This is particularly true at the facility level. (p. 2) 
The ACOG committee opinion is congruent with the Clark et al., 2013 article, 
emphasizing that clinically valid reasons for not following standardized protocols or 
checklists should be documented in the clinical record when deviations purposefully 
occur or are planned. 
 This eighth reviewed paper, by Timmins and Clark, (2015), is a very detailed 
explanation of the great necessity for the development of a standard such as the 
Category II FHR tracings unambiguous interpretation, management, and intervention 
algorithm with its clarifications for use in algorithm; the history leading up to this 
development, the reasons why use of this particular Category II algorithm is 
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particularly advantageous, and as well as a series of very complete directions on the 
clinical use of this algorithm with conservative advice on managing and improving fetal 
oxygenation, and improving fetal outcomes. The paper further explains the necessity 
for finding a solid standard to displace the current wide variation in practice currently 
existing for the care of fetuses manifesting Category II heart rate tracings. The lack of 
practice standards for this majority of fetuses yields an undo amount of less than 
desirable results. Timmins and Clark (2015) note: 
In 1990, Roger Freeman observed that the saga of electronic FHR monitoring had 
been “a disappointing story” in that such monitoring had failed to result in any 
significant reduction in rates of neonatal encephalopathy and subsequent 
neurologic impairment but had contributed to the rise in cesarean section 
delivery rate. A quarter of a century later, the situation remains unchanged, yet 
the approach to FHR interpretation and management has remained static. Recent 
data suggest that variation in interpretation and response to abnormal FHR 
patterns is largely to blame and that, as in many other areas of medicine, 
standardization will yield improved outcomes. (p. 371) 
The paper also states that up until the 2013 algorithm was developed, electronic 
fetal monitoring wasn’t living up to its potential. With the use of the unambiguous 
algorithm, the picture is much better, showing lower rates of cesarean deliveries, lower 
oxytocin use rates, better Apgar scores, less NICU admissions, and better labor 
outcomes in general, as demonstrated in the next paper below in this literature review. 
The ninth paper reviewed is authored by Clark et al. (2015), Recognition and 
Response to Electronic Fetal Heart Rate Patterns: Impact on Newborn Outcomes and Primary 
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Cesarean Delivery Rate in Women Undergoing Induction of Labor. The Clark et al., 2015 
study provides solid evidence that the unambiguous definitions for Category II fetal 
heart rate tracings in the Clark et al., 2013 algorithm do make a measureable, positive 
difference in how the labor is managed, and that through its use, the fetus and mother 
also do measurably better as well. 
The 2015 published study was a very large study involving 14,398 women and 
the results of this study were significant. Also significant was the practical use to which 
the algorithm was put, allowing the algorithm to be tested in the field with significant 
positive newborn and maternal outcome results. The paper by Clark et al. (2015), 
provides clear proof that the Category II FHR tracings algorithm does make a 
measureable, positive difference in how the labor is managed, and that through its use, 
the fetus and mother also do measurably better as well. The significant results were: a 
significantly reduced rate of neonatal intensive care unit admission (3.8% vs. 5.2%, P = 
0.01), a significantly reduced rate of Apgar scores less than 7 at 1 and 5 minutes (4.9% 
vs. 6.4%, p = 0.01, 0.6% vs. 1.1%, p = 0.04), and a significant reduction in cesarean 
delivery rate (15.8% vs. 18.8%, p = 0.00). 
 The study population came from the 110 Hospital Corporation of America 
affiliated hospitals with obstetrical and newborn services in 21 states with a total annual 
delivery volume of approximately 207,000 (5-6% of U.S. deliveries).  From April 1, 2013 
until September 30, 2013, a total of 14,398 patient charts from singleton, term fetuses 
undergoing labor induction with oxytocin were examined sequentially in a non-
random, prospective manner, by a Hospital Corporation of America regional nurse, 
certified as a Fetal Heart Rate Monitor instructor by the Association of Women’s Health, 
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Obstetric and Neonatal Nurses (AWHONN). Each 30-minute segment of the FHR 
tracing, where oxytocin was infused, was examined and the FHR tracing data was 
compared to an evidence-based oxytocin/FHR tracing safety checklist. Unless each 
segment met the oxytocin/FHR tracing safety checklist standard, the oxytocin dose was 
to be reduced. The every-30-minute FHR and uterine activity safety checklist elements 
used were:  
1. At least 1 acceleration of 15 bpm x 15 seconds in 30 minutes is observed, or 
adequate variability is present for 10 of the previous 30 minutes. 
2. No more than 1 late deceleration occurred in the previous 30 minutes. 
3. No more than 2 variable decelerations exceeding 60 seconds in duration and 
decreasing greater than 60 bpm from the baseline occurred within the 
previous 30 minutes. 
4. No more than 5 uterine contractions in 10 minutes for any 20-minute interval. 
5. No 2 contractions greater than 120 seconds duration. 
6. Uterus palpates soft between contractions. 
7. If intrauterine pressure catheter is in place, Montevideo units must calculate 
less than 300 mm Hg and the baseline resting tone must be less than 25 mm 
Hg (Clark et al., 2015, Table 1, p. 494.e2). 
Clinical outcomes in the experimental population included a significant reduction in 
low 1 and 5 minute Apgar scores, a significant reduction in cesarean births, as well as a 
significant reduction in NICU admissions when the oxytocin infusion rate was reduced 
during periods of uterine tachysystole (more than 5 contractions in a 10 minute period). 
Of great interest on many levels, the authors state that the study results: 
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…stand in contrast to several previous reports comparing EFHRM (electronic 
fetal heart rate monitoring) with intermittent auscultation…Most studies 
comparing EFHRM to intermittent auscultation were designed with the 
assumption that those clinicians interpreting and acting upon the information 
gleaned from EFHRM were interpreting and acting correctly. Yet no attempt was 
made to validate these assumptions; in fact, no unambiguous definition of either 
correct interpretation or proper clinical response was provided. This assumption 
of uniform expertise and appropriate reaction to abnormal FHR tracings is 
especially surprising in light of the well-established inability even of individuals 
identified as experts to agree on FHR interpretation. In contrast, for purposes of 
this study we defined abnormal FHR patterns in a completely unambiguous 
manner and similarly defined a specific appropriate reaction when such patterns 
were observed. (pp. 494e2-494e3) 
As noted in this 2015 article, the data gathered in this study, show a clear 
congruence between the process outlined in Intrapartum Management Of Category II Fetal 
Heart Rate Tracings: Towards Standardization Of Care (Clark et al., 2013), and the results 
described in Recognition and Response to Electronic Fetal Heart Rate Patterns – Impact on 
Newborn Outcomes and Primary Cesarean Delivery Rate in Women Undergoing Induction of 
Labor (Clark et al., 2015).  
The objective of the study was to see if unambiguous definitions of abnormal 
FHR could improve patient outcomes when applied to women in induced labor using 
oxytocin. This study was the first attempt to use the Category II FHR tracings algorithm 
on a wide scale with one of the controversial areas in obstetrics, oxytocin induced labor. 
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The idea of the study design was to simultaneously seek possible evidence that use of 
the unambiguous definitions of abnormal FHR tracings, which are a part of the Clark et 
al., 2013 Category II FHR tracings algorithm, is effective, and to see if it can be applied 
successfully to give safer control to healthcare personnel over the use of oxytocin. So 
that IV oxytocin is properly administered at ideal rates of infusion, the patients, mother 
and fetus, are closely monitored using electronic FHR monitoring, for signs of FHR 
compensatory patterns or tachysystole, so that oxytocin infusion rates can be reduced or 
stopped, if necessary, in an effort to bring the FHR tracings back into a Category I 
pattern. As mentioned by Simpson (2014a), the cesarean delivery rate is expected to 
exceed 50% by 2020 in the United States. Elective induction of labor has declined from 
23.8% in 2010, to 23.3% in 2012, but is still very common (Centers for Disease Control 
and Prevention, 2014; Osterman & Martin, 2014). What this means is that patients who 
are not in labor are sometimes scheduled by their healthcare providers, either for 
medical indications or for elective reasons, to attempt stimulating labor, using a cervical 
ripening agent, mechanical induction with a silicone cervical balloon or cervical Foley 
catheter, or artificial rupture of the amniotic membranes treatment, and/or intravenous 
oxytocin, rather than waiting to go into spontaneous labor. The study published in 2015 
by Clark et al., looked at improving neonatal outcomes and lowering cesarean birth 
rates for induced labors by finding ways to protect the fetus during labor, and help 
labors to progress to a successful outcome by more skillfully intervening in a timely 
manner. Using unambiguous methods for Category II FHR tracings interpretation with 
the associated standards of care, and the in-use checklist used by this study encouraged 
appropriate conservative corrective measures for Category II FHRs, which could 
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include supplemental oxygen, maternal position changes, intravenous fluid 
administration, correction of hypotension, reduction or discontinuation of uterine 
stimulation, administration of a uterine relaxant, amnioinfusion, and/or changes in 
second stage breathing and pushing techniques. 
The results demonstrated statistically significant correlation between the 
recognition of danger to the fetus based on an unambiguous interpretation of Category 
II FHR tracings revealing the need to intervene, and the act of reducing or discontinuing 
oxytocin, when indicated. This relationship of cause and effect significantly lowered the 
rate of neonatal NICU admission by one third, resulted in fewer low one and five 
minute Apgar scores < 7, as well as significantly lowered the cesarean birth rate from 
18.8% to 15.8%. The large size of the study was also important, since this helped point 
up significant results that might have either not been identified or been difficult to 
recognize. This evidence answers those who questioned the Category II FHR tracings 
algorithm when first published, as having no evidence to support it, as well as helping 
answer those who felt that continuous intrapartum electronic fetal monitoring was not 
useful. With this study, there is now stronger evidence of the validity of the Category II 
FHR tracings algorithm and continuous electronic FHR monitoring during induced 
labors. It is also clear that more and varied studies are necessary to further validate 
these methods, particularly from researchers outside the group that conceived and 
constructed the Category II FHR tracings algorithm. This is necessary to test its 
universality, and its applicability for general use among the obstetrical community. In 
the conclusion by Clark et al. (2015), it is stated, “electronic FHR monitoring improves 
neonatal outcomes when unambiguous definitions of abnormal FHR and tachysystole 
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are coupled with specific interventions.” 
The tenth research paper, written by Clark et al. (2016), entitled Use of a 
Standardized Protocol for the Management of Category II Fetal Heart Rate Tracings Leads to 
Earlier Intervention in Infants Born with Metabolic Acidosis, is also important. It looks at the 
idea of producing better outcomes, by blind analyzing 240 births, using the Clark et al., 
2013 algorithm, after the fact, to see if by using the algorithm, earlier intervention 
would have happened, yielding an improved outcome for the 120 fetuses with 
significant metabolic acidosis. This smaller study, of 240 fetuses, half of whom were 
born with prolonged hypoxia evidenced by significant metabolic acidosis (umbilical 
artery base deficit >12mM/L), and half of whom had normal umbilical artery base 
deficit levels (<8mM/L), showed that use of the algorithm would have resulted in a 
significantly higher rate (p=0.016) of earlier delivery of infants with significant 
metabolic acidosis. This study also noted that in the case of the 120 fetuses without 
significant acidosis, also blind analyzed, using the Clark, et al., 2013 algorithm, that 
using the algorithm would not have resulted in significantly earlier intervention 
(p=1.0). 
It is clear that the Clark et al., 2013 consensus group has a clear vision of where 
they want to go. They want to put in place a standard for accurately interpreting FHR 
tracings, and for specific standards for fetal and maternal interventions based on those 
unambiguous FHR tracings interpretations. This 2015 manuscript of Clark et al. is 
clearly constructed to validate the FHR tracings algorithm and the associated 
recommendation for standards of care using a large number of clinical cases, so that the 
value of the concept can be proven and the construct may be more readily adopted by 
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the rest of the healthcare community. With the 2015 and 2016 manuscripts, Clark and 
his colleagues made major contributions to the health and safety of mothers, fetuses, 
and families, and have raised the bar for intrapartum quality care. It is now even more 
clear that more research is needed to further test, improve, and validate this Category II 
FHR tracings algorithm, and work for national adoption of a clear and effective set of 
standards and recommendations for patient care in the setting of Category II FHR 
tracings.  
Discussion 
 Because of the recentness of publication of the 2013 Category II FHR tracings 
algorithm, very little research has been done to validate and improve the technique. 
Within the first 3 years of publication, using a Web of Science Database search, the 2013 
Clark et al. article was found to have been cited in a mere 22 publications. Only seven 
published writings were found which discussed, used, or referenced the algorithm in 
any depth. Of those, five of them discussed or inferred possible uses for the algorithm 
in clinical settings, and only two (Clark et al., 2015), (Clark et al., 2016) were actual 
research efforts, though one was a rather large one, which utilized the unambiguous 
definitions for Category II FHR tracings, and produced strong evidence of its efficacy of 
use (Clark et al., 2015).  
 The Category II FHR tracings algorithm (Clark et al., 2013) was only published in 
2013, in answer to a need to address the necessity for a way to unambiguously interpret 
Category II FHR tracings, and when needed, carry out prompt and meaningful 
interventions to benefit the fetus and the mother during labor. Without the 2013 
Category II FHR tracing algorithm, the situation can be chaotic, with individuals or 
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small groups using various interpretation methods, which may be at odds with each 
other. The situation for interventions based on those disparate interpretations of 
Category II FHR tracings can also be in disarray, since there is no current national 
standard on deciding what to do and when to do it appropriately for Category II FHR 
tracings. With the NICHD 3-tier system, Category I was classed as normal, Category III 
was classed as abnormal, and Category II was simply classed as indeterminate (ACOG, 
2009, 2010; Druzin, 2010; Macones et al., 2008a, 2008b). Clinicians in obstetrics have 
clear national recommendations on what to do when the 16-20% of fetuses have heart 
rate tracings that are purely Category I, or for the relatively few fetuses that have 
Category III tracings, but not so when the 80% of fetuses who have FHR tracings which 
are Category II are in labor and delivery.  
In 2013, eighteen of some of the foremost U.S. experts in the field of FHR tracings 
interpretation, headed by Clark, collaborated and published a journal article to alleviate 
this problem. They went through the existing science and research related to Category II 
electronic FHR tracing interpretation and intervention, and pooling their decades of 
experience, developed an unambiguous Category II FHR tracings algorithm. Out of that 
process was built a Category II FHR tracings decision tree to guide users of the 
algorithm in how to decide when and how to intervene appropriately in the labor and 
birthing process. In addition to this decision tree, a table was created, with a series of 
ten recommendations for standards of care based on the Category II FHR tracings 
algorithm, called “Management of Category II FHR patterns: clarifications for use in 
algorithm,” which goes into great detail on how and when to use the algorithm in 
clinical settings. Also in the 2013 algorithm paper, are sixteen further useful 
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recommendations and cautions related to using the algorithm (See Appendix). 
The strength of the algorithm is that the people who developed the algorithm 
have had wide and profound experiences in the field, and are authors of many 
hundreds of far-reaching pieces of applicable obstetrics research over the past 2 to 5 
decades. They also came from many different backgrounds, and had tremendous 
amounts of the accumulated science and clinical knowledge about electronic fetal 
monitoring interpretation and intervention available to them. Lastly, they came 
together determined to solve the crisis over Category II FHR tracings interpretation and 
intervention, and discovered a system for re-classifying Category II FHR tracings from 
ambiguous to unambiguous, and standardizing Category II FHR tracings interpretation 
and intervention.  
The main weakness with the 2013 unambiguous algorithm and its 
recommendations for standards of care and use, was that as written, it had never been 
tested in a large scale research effort in a clinical setting to see if it worked, and to see if 
it would make a significant positive difference in fetal and maternal outcomes. This 
aspect was discussed in the original paper recommending that research be done using 
the algorithm in clinical settings to see how it fared. Others in the research community 
also pointed to the need for scientific evidence of its efficacy.  
Some authors subsequently wrote suggesting various scenarios in which the 
algorithm might prove itself useful, but no one actually published a research effort 
providing scientific evidence gathered from a clinical setting.  
In April of 2015, the American Journal of Obstetrics and Gynecology published 
the findings of a very large research effort spear-headed by Clark, one of the authors of 
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the original 2013 algorithm. This 33-page article described a clinical research effort 
involving 14,398 subjects, a massive research effort. This study used the algorithm and 
recommendations authored by Clark et al. (2013) to compare clinical outcomes of 
patients in which the algorithm was followed, with control patients in which the 
components of the 2013 algorithm were not followed. For example, in the experimental 
group, when specific Category II FHR tracings were identified, and oxytocin was 
consequently reduced or discontinued, there were less substandard newborn outcomes. 
As a result, the number of NICU admissions also dropped significantly by one third. 
Lastly, the cesarean delivery rate also dropped significantly from 18.8% to 15.8%, due to 
better labor management based on unambiguous use of the Category II FHR tracings 
algorithm. The inverse relationship between cesarean birth rates and healthy neonates 
need not hold true when careful adherence to unambiguous definitions of abnormal 
FHR patterns and standardized patient safety recommendations are followed. It is then 
possible to lower the cesarean delivery rate, while simultaneously taking good care of 
the fetuses, yielding much lower adverse outcome risks for the mothers and for the 
babies. Since the Clark et al. (2015) clinical study dealt exclusively with a group of 
oxytocin induced women, the results may not be applicable to other dissimilar groups 
of women in labor.  
In the most recent 2016 published clinical study, the algorithm was used post-
facto to blind review FHR tracing data from 120 fetuses with severe metabolic acidosis. 
The methodology in the 2016 study is thus similar to the methodology outlined by  
Van Hoose (2014), which is the basis for this dissertation research (See Chapter III).  
As more research efforts using the 2013 unambiguous Category II FHR tracings 
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interpretation and intervention algorithm are carried out, the algorithm will have 
appropriate validation with regarding its efficacy. In the Clark group’s 2013 article, 
which explains the new algorithm and recommendations for standards of care for 
Category II FHR tracing interpretation and intervention strategies, the healthcare 
community is requested to test this algorithm and report on its level of efficacy. 
Implications for Research and Knowledge Development 
 Since, at this point in time, there have been only two published clinical research 
efforts to evaluate the efficacy of the Clark et al., 2013 Category II interpretation and 
management algorithm (Clark et al., 2015, 2016), there are many opportunities for 
research efforts around the world to further test and improve the efficacy of this 
unambiguous Category II FHR interpretation and intervention algorithm. Some of these 
efforts could be international, so as to take advantage of the different Category I, II, and 
III standards that exist outside of the United States that could be melded into this 
algorithm and vice versa, to our mutual benefit. The two research opportunities used in 
this research effort are discussed below. 
 An opportunity to test the algorithm on a different set of fetal heart rate 
tracings from those used by Clark, et al., 2015. This allowed the production of further 
evidence as to the efficacy of the Clark et al. 2013 unambiguous Category II FHR 
algorithm decision tree and the associated list of ten main “management of Category II 
FHR patterns: clarifications for use in algorithm,” as well as the sixteen additional 
management per algorithm recommendations for care based on the fetal status and 
labor progress.   
 An opportunity to test the algorithm against other regions’ standards, and 
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using electronic fetal heart rate monitors output used in other regions. There are 
electronic fetal heart rate monitors built and used in regions outside the United States, 
designed for fetal heart rate tracings interpretation and intervention standards different 
from those used in the United States. Research on the efficacy of the Clark et al., 2013 
Category II fetal heart rate tracings algorithm when used on other regions’ electronic 
fetal heart rate monitors, in concert with the other regions’ fetal heart rate tracings 
standards, might yield an international standard better than either alone. 
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CHAPTER 3  
METHODOLOGY 
Purpose of the Study 
The purpose of this study was to test the Algorithm for Management of Category II 
Fetal Heart Rate Tracings, created by Clark et al. (2013), to generate more evidence to 
evaluate its utility for improved efficacy in the interpretation and clinical management 
of Category II fetal heart rate tracings. 
Specific Aim 1. The first specific aim of this study was to test the Clark et al. 
Category II fetal heart rate monitoring algorithm on 552 fetal heart rate tracings 
(Chudáˇcek et al., 2014) without reference to the original decisions made and 
interventions carried out at the time each strip was made, to see if the algorithm 
decision tree and associated extensive “clarifications for use in algorithm,” gave 
unambiguous direction on interpretation and intervention for these 552 fetal heart rate 
tracings, which would potentially yield better fetal (higher Apgar scores, less acidosis, fewer 
admissions to NICU, less neurological and other damage, etc.) and maternal (fewer cesarean 
births, fewer operative vaginal deliveries, more successful spontaneous vaginal deliveries) 
outcomes, as it has in the two Clark et al. 2015 and 2016 research efforts. 
Research Question 1. Will Clark et al.’s (2013) Algorithm for Management of 
Category II Fetal Heart Rate Tracings reliably give unambiguous direction on 
interpretation and intervention for Category II fetal heart rate tracings? 
Specific Aim 2. The second specific aim of this study was to generate more 
evidence regarding the efficacy of the Clark et al. Category II fetal heart rate tracing 
algorithm. 
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Research Question 2. Can using the Clark et al.’s (2013) Algorithm for 
Management of Category II Fetal Heart Rate Tracings on the 552 fetal heart rate and uterine 
contraction tracings result in different recommendations for management and 
intervention forecasting a possibly improved outcome over the actual result? 
Research Design  
This study design was a blind retrospective secondary analysis of an anonymous 
set of public access archived files of 552 fetal heart rates tracings in the 30-90 minutes 
preceding delivery, acquired in the obstetrics ward at the University Hospital in Brno, 
Czechoslovakia (Chudáˇcek et al., 2014). The database is located online at: 
http://physionet.org/physiobank/database/ctu-uhb-ctgdb/. The electronic fetal heart 
rate and uterine contraction tracings were stored in OB TraceVue® form. Exclusion 
criteria used by Chudáˇcek et al. (2014) to reduce the number of tracings to 552 before 
being uploaded for availability in an open access intrapartum CTG database were: 
Maternal age < 18 years, fetal weeks of gestation ≤ 37, known fetal diseases – congenital 
defects or intrauterine growth restriction. Inclusion criteria were for only singleton, 
uncomplicated pregnancies. Chudáˇcek et al. (2014) also provided umbilical artery 
blood pH with each of the fetal heart rate tracings.  
Research Methodology 
Each of the 552 fetal heart rate tracings and associated maternal uterine 
contraction tracings was blind analyzed using the Clark et al. (2013) Category II 
algorithm decision tree and associated standards of care. The fetal heart rate tracings 
were blind analyzed without access to or reference to the original outcomes, decisions 
made, and interventions carried out at the time each strip was recorded. The analyses 
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evaluated the fetal heart rate tracings related to maternal uterine contraction patterns, 
and made notations when any of the following were visible:   
1). Absence of moderate variability or accelerations in the baseline that continue for ≥ 30 
minutes. 
2). Recurrent late decelerations of the fetal heart rate. 
3). Recurrent significant variable decelerations of the fetal heart rate (lasting > 60 
seconds, decelerations deeper than 60 beats per minute below the baseline rate, or going 
lower than 60 beats per minute). 
4). Any prolonged deceleration (algorithm use should be discontinued until prolonged 
deceleration is resolved) (See Figure 7). 
 
 
 
 
 
Figure 7. Criteria for data collection 
 
Based upon the presence of any of the four above characteristics, analyses also 
noted movement from one action state to another on the algorithm decision tree 
Recurrent late 
decelerations 
Recurrent 
significant 
decelerations 
Absence of 
moderate 
variability or 
accelerations 
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(Manage Per Algorithm, Observe, Cesarean or Operative Vaginal Delivery, or Cesarean 
Delivery), and on that basis, recommended a specific intervention or set of interventions 
to be carried out at each of those points in time along the tracing. This was done for 
each of the 552 fetal heart rate tracings until the endpoint of the actual delivery, the end 
of the tracing, or an analysis per algorithm recommended delivery point was reached. 
The fetal heart rate tracings had no annotations, notes, or any other information on 
them. All of the notes, outcomes, labor, and birthing information, etc., are contained in a 
separate text file with the same file number as the associated fetal and maternal heart 
rate tracing file. After the analyses per algorithm had been completed on all 552 fetal 
heart rate tracings, a comparison of the algorithm-driven fetal, labor, delivery 
management and probable outcome with actual labor and delivery timing and mode 
from the associated separate information text file were made to estimate fetal, labor 
management and outcome differences in newborn status, operative vs. non-operative 
delivery, and timing of delivery. This methodology made possible comparisons 
between the actual labor management, intervention(s), and outcome; and the algorithm-
driven labor management, intervention(s), and outcome. The most important 
statistically measureable set of outcomes were how much earlier the algorithm-driven 
delivery time is for each of the fetuses with problematic fetal heart rate tracings, 
compared to the actual delivery time for this same set of fetuses. Also possible was that 
of more algorithm-driven operative vaginal and cesarean deliveries than in the actual  
outcomes group as described in the associated information header files. These same 
statistical comparisons were also made with those fetuses with non-problematic fetal 
heart rate tracings, to see if unnecessary interventions were produced, by using the 
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algorithm-driven analyses. This comparison yielded potentially superior labor-process 
management, better and more timely intervention(s), and an improved neonatal and 
maternal outcome. Further proof of the efficacy of the Clark et al. fetal heart rate tracing 
algorithm and its associated extensive “clarifications for use in algorithm” (Clark et al., 
2013) was one of the products of this study.  
Data Collection 
The 552 tracings data files and the associated 552 tracings information files from 
the Chudáˇcek et al. (2014) open access intrapartum CTG database were downloaded to 
the database folder on an Apple Macintosh computer for organizing, processing, 
transfiguring, optimization, and display. The tracings data files each contain a fetal 
heart rate tracing with the maternal uterine contraction tracing. The separate associated 
information files each contain data on fetal gestational age, maternal parity and 
gravidity, maternal age, known perinatal diseases, type of delivery, fetal sex, risk 
factors, intrapartum drugs, induced vs. spontaneous labor, fetal presentation, 
intrapartum risks or diagnoses umbilical artery pH and base excess/base deficit, 
newborn weight, Apgar scores, and amount of missing signal time for each associated 
data file (See Glossary). Each information header file (.hea) was matched with a unique 
file number to each data file’s (.dat) matching unique file number.  
Each of the 552 tracings information header files (See Figure 8) have a separate 
matching 30-90 minute heart rate tracings/maternal uterine contraction tracings data 
file (See Figure 9). 
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Figure 8: Example Of an Associated Fetal Heart Rate Tracing Information File 2045.hea. 
Copyright 2014 by Chudáˇcek. Reprinted under terms of the Creative Commons 
Attribution License. 
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The maternal uterine contraction tracing runs parallel with the fetal heart rate 
tracing in the same tracings data file. When displayed, each data file has the fetal heart 
rate tracing along the top of the tracing and the maternal uterine contraction tracing 
running along parallel just below the fetal heart rate tracing. The interaction of the two 
parallel tracings was compared and contrasted with each other along the entire length 
of each tracing. A curser-driven readout allowed accurate fetal heart rate numerical 
reading at any point of the tracing (See Figure 10). 
 
Figure 9: Short Example Of Fetal Heart Rate & Maternal Uterine Tracings Data File 
Number 2045.dat (fetal heart rate varies from 123 bpm to 151 bpm in this trace). 
Copyright 2014 by Chudáˇcek. Reprinted under terms of the Creative Commons 
Attribution License. 
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Each of the 552 fetal heart rate tracings and each parallel maternal uterine 
contraction tracings were blind analyzed using the Clark, et al. unambiguous Category 
II algorithm decision tree and the associated list of ten main “management of Category 
II fetal heart rate patterns: clarifications for use in algorithm,” as well as the sixteen 
additional management per algorithm recommendations for care based on the fetal 
status and labor progress (For a thorough discussion of the above algorithm, ten 
clarifications, and sixteen recommendations, see Appendix). Each of the 552 analyses 
followed the method described at length in the previous research design area of this 
paper. Briefly, each of the 552 fetal heart rate tracings/maternal uterine contraction 
tracings, was blind analyzed using the Clark et al., 2013 algorithm decision tree, the 
associated list of ten main “management of Category II fetal heart rate patterns: 
clarifications for use in algorithm,” as well as the sixteen additional management per 
algorithm recommendations for care based on the fetal status and labor progress. The 
algorithm-driven analysis of each fetal heart rate tracing was compared to the actual 
outcome information contained in the separate information header file associated with 
each of the 552 fetal heart rate tracings/maternal uterine contraction tracings data files. 
The algorithm-driven analyses comparisons were made to see if there was, or was not,  
a significant difference in the time to delivery in the case of fetuses showing evidence of 
lack of moderate variability/accelerations lasting >30 minutes with recurrent late 
decelerations, recurrent variable decelerations lasting >60 seconds with nadirs less than 
60 bpm or > 60 bpm below baseline, or with prolonged decelerations in their fetal heart 
rate tracings. If moderate variability/accelerations were present, then up to 1 hour of 
significant decelerations could be observed before an early delivery intervention. There 
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was a difference between the total number of earlier delivery times of algorithm-driven 
births, and the total number of actual delivery times described in the information 
header files. Each of the 552 per algorithm analyses was entered into an array using the 
original tracings data file number for identification. This was necessary to avoid 
confusion, as the tracings data file numbers and header information file numbers both 
start at 1001, run sequentially up to 1506 and stop; start again at 2001 and run 
sequentially through to 2046 and end there. After the 552 tracings data files had been 
analyzed with the Clark et al., 2013 unambiguous Category II algorithm and associated 
extensive “clarifications for use in algorithm,” then the 552 header information files 
were entered into the analysis array next to the tracings data file analysis with the same 
file number. At that point, each header information file was compared each associated 
tracing data file per algorithm analysis, with the actual outcomes information from each 
tracings header information file with the same file number. When all of the comparisons 
between the analysis per algorithm decisions and management information, versus the 
actual outcome information were made, there was a noticeable improvement when 
contrasting the unambiguous algorithm probable outcomes over the associated actual 
outcomes, as the algorithm driven analyses worked as predicted. When the earlier time 
to delivery percentages were compared, there was an important, but non-statistically 
significantly shorter time to delivery difference in favor of the algorithm-driven 
analyses in the earlier delivered group. There was higher rate of operative deliveries 
recommended in the algorithm-driven group as well, potentially yielding better fetal 
and maternal outcomes. 
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Description of Data from Chudáˇcek et al., 2014 Open Access intrapartum CTG 
Database 
The 552 fetal heart rate tracings/maternal uterine contraction tracings in the 
public access database created by Chudáˇcek et al. (2014), were selected from the 14,492 
deliveries gathered between April 2010 and August 2012 at the obstetrics department of 
the University Hospital at Brno, located in the Czech Republic. The data was of two 
types; intrapartum fetal heart rate tracings/maternal uterine contraction tracings, and 
for each set of tracings there was an information header file containing the associated 
clinical data. The tracings were collected using a variety of fetal monitoring machines: 
STAN S21 and STAN S31 made by Neoventa Medical, Sweden; and Avalon FM40 and 
FM50 made by Phillips Healthcare, USA. A total of 9,164 individual tracings were 
recorded, from which the 552 tracing were meticulously selected using the following 
clinical and technical criteria: Women’s age, greater than 18 years old; weeks of 
gestation, more than 37 weeks; no known fetal diseases, no congenital defects or 
intrauterine growth restriction; type of gravidity, only uncomplicated, singleton 
pregnancies allowed; and exclude records with missing umbilical artery pH; and type 
of delivery. The 552 deliveries included 417 vaginal (pH>7.15), 89 vaginal (pH<7.15), 30 
cesarean (pH>7.15), 16 cesarean (pH<7.05).  Other clinical criteria were: Fetuses of both 
genders are included; risk factors included were gestational diabetes, preeclampsia, 
maternal fever (>37.5 °C), hypertension, meconium stained fluid; and information on 
why operative delivery was used was not included, if there was induced labor, 
presentation type (occipital/breech), no labor progress, dystocia cephalocorporal 
(incoordinate uterine activity, and dystocia cephalopelvic). The fetal heart and maternal 
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uterine signal criteria were: Signal length, the ninety minutes before the delivery (Stage 
I maximum sixty minutes, Stage II maximum thirty minutes); missing signal, no more 
than fifty percent of the tracing; noise and artifacts, some recordings contain maternal 
heart rate sometimes present (typically when ultrasound doppler probe is used); and 
fetal tracings instrument used, a mix of ultrasound doppler probe and/or direct scalp 
measurement. Since, according to the authors, these sorts of tracings are typical of the 
obstetrics department at University Hospital at Brno (and in hospitals around the U. S. 
as well), they can be interpreted in that context by healthcare personnel skilled in fetal 
heart rate tracings/maternal uterine contraction tracings analysis. This Physiobank 
(Goldberger et al., 2000) database (http://physionet.org/physiobank/database/ctu-
uhb-ctgdb/) was designed to be used by researchers as a basis for studies, which can be 
cross-compared with one another, or as the basis for research comparing this database 
to other similar databases of fetal heart rate tracings/maternal uterine contraction 
tracings. The database consists of 552 fetal heart rate tracings/maternal uterine 
contraction tracings data files (.dat), and 552 associated separate tracings information 
files (.hea). The Chudáˇcek et al., 2014 open access intrapartum CTG Database on 
physionet.org, consists of a listing of 1104 alternating data and information files in MIT 
Waveform Database format. To decode and display this data as fetal heart rate 
tracings/maternal uterine contraction tracings electronic digital waveforms, it is 
necessary to unpack, install, and properly configure Open Source WFTD Processing 
GNU-Based Unix software (this process is complex and outside the scope of this paper). 
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Sample Characteristics 
The data is comprised of 552 electronic fetal heart rate tracings/maternal uterine 
contraction tracings data files and associated separate tracings information files. 
Inclusion criteria. The data includes only the 552 data and separate information 
files from the Chudáˇcek et al., 2014 open access intrapartum CTG Database. 
Exclusion criteria. Exclusion criteria used by Chudáˇcek et al. to reduce the 
number of tracings from 14,492 to 552 before being uploaded for availability in an open 
access intrapartum CTG database are: Exclude maternal age < 18 years, weeks of 
gestation - include only fetal weeks of gestation > 37, exclude known fetal diseases – 
congenital defects or intrauterine growth restriction, include type of gravidity - only 
singleton, uncomplicated pregnancies and excluded records with missing umbilical 
artery pH.  
Detailed information on inclusion, exclusion and other criteria are discussed in 
the Description of Data section above. 
Statistical Approach For Analysis Of The Data 
The two-sample z-test for proportions was one of the two statistical methods, 
which were utilized in this research. This approach was used to compare two different 
percentage/proportion outcomes of some phenomena involving two sub-groups of a 
larger group. The z-test yields a ‘p’ score, which is a measure of the significance of the 
relationship between the two proportions (percentages). The second statistical method 
was the 2X2 Fischer’s Exact Test. This statistical method also yields a ‘p’ score, which is 
also a measure of the significance of the relationship between the two percentages 
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(proportions). These two statistical methods were very useful individually and in 
combination to address those data which lent themselves to statistical analysis. When 
used in parallel, they yielded the same significant ‘p’ scores, thus cross-validating those 
results. 
On a side note, Clark, et al. (2016) used Chi-Square for trends, and for tests of 
proportions, they used Fischer’s Exact Test (personal communication from E. Hamilton, 
MD, on 09/19/2016) on their somewhat similar datasets. The statistical method and the 
associated statistical test used by Clark et al., 2016, also produce ‘p’ scores, which can be 
compared. A 2x2 table for each of Clark et al., 2016 statistical methods was used to 
generate a pair of percentages (proportions), which can be used to calculate the ‘p’ score 
in each instance. Since both of their ‘p’ scores are significant (at the 0.05 level), then the 
findings can be seen as valid. Normally, however, Chi-Square is used on large datasets, 
greater than 1000, and Fischer’s Exact Test is used on smaller datasets, less than 1000.  
Protection of Human Subjects 
 The University of Hawai’i Human Studies Program and Institutional Review 
Board did not require IRB approval of this study, because it utilized digital recordings 
and data from a currently existing, publically available database and did not include 
any individual identifiers or involve human subjects (University of Hawai’i Human 
Studies Program, 2015 p. 2). 
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CHAPTER 4 
RESULTS 
This section provides the results of the statistical data analysis carried out on the 
research data generated. The study aimed to verify if using the Clark et al., 2013 fetal 
heat rate monitoring algorithm and associated ten main clarifications for use in 
algorithm, plus the sixteen additional clarifications for fetal and maternal labor 
management would result in improved outcomes when blind analyzing the 552 fetal 
heart and maternal uterine contraction electronic tracings from the Chudáˇcek et al., 
2014 open access intrapartum CTG Database.   
Database Clinical Parameters 
Table 3: Main Clinical Parameters Of Vaginal Delivery 
(Chudáˇcek et al., 2014, File#1471-2393-14-16-S1). Copyright 2014 by Chudáˇcek. 
Reprinted under terms of the Creative Commons Attribution License. 
 
 64 
Table 4: Main Clinical Parameters Of SC Delivery 
(Chudáˇcek et al., 2014, File#1471-2393-14-16-S2). Copyright 2014 by Chudáˇcek. 
Reprinted under terms of the Creative Commons Attribution License. 
 
 
Table 5: Clinical Parameters (Risk Factors and Means of Measurement) Vaginal  
(Chudáˇcek et al., 2014, File#1471-2393-14-16-S3). Copyright 2014 by Chudáˇcek. 
Reprinted under terms of the Creative Commons Attribution License. 
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Table 6: Clinical Parameters (Risk Factors and Means of Measurement) Cesarean  
(Chudáˇcek et al., 2014, File#1471-2393-14-16-S3). Copyright 2014 by Chudáˇcek. 
Reprinted under terms of the Creative Commons Attribution License. 
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Patient Characteristics 
Table 7: Patient And Labor Outcome Statistics 
(Chudáˇcek et al., 2014, p. 7). Copyright 2014 by Chudáˇcek. Reprinted under 
terms of the Creative Commons Attribution License. 
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CTG Signal Characteristics 
Table 8: CTG Signal Characteristics for the CTG-UHB Database 
(Chudáˇcek et al., 2014, p. 8). Copyright 2014 by Chudáˇcek. Reprinted under 
terms of the Creative Commons Attribution License. 
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Statistical Analysis Software 
The IBM Statistical Package for the Social Sciences (SPSS) Apple Macintosh Version 22 
with the Confidence Interval Proportion Tool was used for data analysis. 
Comparison of Ratios. The two research questions explored the differences 
between the ratios/percentages of two sets of analyses outcomes from the same dataset. 
The final decision to use the two-sample Z-test for proportions and the 2 X 2 table 
Fischer’s Exact Test was based on the data generated, as well as the form of the 
comparison of the blinded and un-blinded analyses used. Both of these methods 
detected a statistically significant difference between two proportions/percentages. The 
decision to use both statistical analysis methods, was to compare the two statistical 
results to see if they were significant at a similar level as a form of cross-validation. 
Sample Characteristics 
 The final analyses samples either are or were extracted from the entire 
Chudáˇcek et al. 2014 open access intrapartum CTG Database.  
 Each of the 552 fetal heart rate tracings came from babies who had no severe 
morbidity, no NICU days, no seizures, no diagnosis of hypoxic ischemic 
encephalopathy (HIE), and no intubation. However, very vigorous resuscitation and 
support required at delivery can be assumed for the 37 babies in the dataset with one-
minute Apgar scores of 5 or less. Twenty babies also had 5 minute Apgar score of 6 or 
less. 
A very significant predictive effect of the presence of Category II FHR was 
observed in all but two of the 177 fetal heart rate tracings from babies with umbilical 
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artery pH at birth less than 7.20 (the traditional definition of fetal academia).  
As the 552 fetal monitoring strips were being blind analyzed, the strips looked 
typical regarding the amount of missing data (fetal heart rate and uterine contraction), 
the differences when shifting between external fetal heart rate monitoring and fetal 
scalp lead monitoring and probable oxytocin use detection. 
Data Analyses Parameters 
Because of the nature and structure of the Clark et al., 2013 FHR monitoring 
algorithm, and ten main, and the sixteen additional clarifications for use in algorithm, 
the blind analyses per algorithm were carried out at several different, yet related and 
connected levels.  
The first level, was identifying those FHR monitoring strips which, according to 
the algorithm, were identified as having urgent Category II status, which recommended 
an earlier radical intervention, per algorithm, of either an operational vaginal delivery 
(vacuum extractor or forceps), or a cesarean delivery. In actual practice, in the case of 
Category II status fetuses, conservative methods should be tried earlier in the tracing, 
unless a sentinel event has occurred, requiring immediate, radical action, to save the 
patient(s).  Unfortunately, in the analysis of post-facto strips such as these, it was not 
possible to use conservative interventions to improve the fetuses’ Category II status, as 
would be the case, if they were currently in progress, due to the need for immediate 
action.  
The second level of analysis, was identifying those FHR monitoring strips, which 
required a conservative intervention, per algorithm, to rescue the fetus from Category II 
status (indeterminate), and return it to Category I status (normal). Conservative 
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interventions include, but are not limited to: supplemental oxygen, maternal position 
changes, intravenous fluid administration, correction of hypotension, reduction or 
discontinuation of uterine stimulation, administration of a uterine relaxant, 
amnioinfusion, and/or changes in second stage breathing and pushing techniques.  
A third level of analysis, was to explore the supposition that use of the algorithm 
could potentially reduce the number of OVD’s and cesarean deliveries, and instead 
allow more normal spontaneous vaginal deliveries. 
Specific Aim 1 
The first specific aim of this study was to test the Clark et al., 2013 Category II 
fetal heart rate monitoring algorithm on 552 fetal heart rate tracings (Chudáˇcek et al., 
2014) without reference to the original decisions made and interventions carried out at 
the time each strip was made, to see if the algorithm decision tree and associated 
extensive “clarifications for use in algorithm,” gave unambiguous direction on 
interpretation and intervention for these 552 fetal heart rate tracings, which would 
potentially yield better fetal (higher Apgar scores, less acidosis, fewer admissions to NICU, less 
neurological and other damage, etc.) and maternal (fewer cesarean births, fewer operative vaginal 
deliveries, more successful spontaneous vaginal deliveries) outcomes, as it has in the two Clark et 
al., 2015 and 2016 research efforts. 
Research Question 1  
Will Clark et al.’s (2013) Algorithm for Management of Category II Fetal Heart Rate 
Tracings reliably give unambiguous direction on interpretation and intervention for 
Category II fetal heart rate tracings? 
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Research question 1 sought to ascertain if Clark et al.’s (2013) Algorithm for 
Management of Category II Fetal Heart Rate Tracings, algorithm decision tree and 
associated extensive “clarifications for use in algorithm,” gave unambiguous direction 
on interpretation and intervention for Category II FHR tracings. 
Highly significant algorithm-driven evidence was discovered giving very useful 
unambiguous direction for interpreting and intervening when observing Category II 
FHR tracings. 
 Post facto reading comparison of the actual results showed eighteen of the 177 
header files with pH less than 7.20 had severe fetal metabolic acidosis base deficit 
extracellular fluid levels (BDecf) over 12.0, and another 45 header files reported fetal 
metabolic acidosis evidenced by abnormally high base deficit extracellular fluid levels 
(BDecf)  over 8 but less than 12.  Seven of the 177 data files with pH less than 7.20 had 
missing base deficit extracellular fluid levels (BDecf) records.  
The blind analysis per algorithm correctly identified all but two of the 177 FHR 
tracings with a pH below 7.20 as Category II, requiring interventions to relieve the 
stressors on the fetuses and return them to Category I (Normal) status. In this study, the 
algorithm-driven conservative interventions recommended, were found to be indicated 
in all except two of the 177 FHR tracings with pH less than 7.20 for Category II FHR 
tracings. These blind analyses conservative interventions, discovered by utilizing the 
Clark et al. (2013) algorithm decision tree and associated extensive “clarifications for use 
in algorithm with Category II FHR tracings, could potentially for improve fetal pH, base 
deficit, Apgar scores, and non-operative delivery rates. There were a total of 17 
algorithm-driven recommended radical interventions (OVD or cesarean), all with a 
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birth pH of 7.18 or less (8 had pH less than 7.0, with the other 9 babies having umbilical 
artery pH from 7.0 to 7.18).  An additional 11 FHR tracings with pH ≤7.20 were found to 
meet the criteria for radical intervention per algorithm within 5 minutes of the tracing 
end. These findings and others are described in more detail under Research Question 2. 
The sensitivity of the algorithm makes these levels of findings and the solutions to them 
finally possible. Without the algorithm, these Category II FHR tracings could remain 
indeterminate, and possible interventions, and when and what to use, might not be 
utilized. The database contained only forty-six cesarean deliveries, and the forty-four 
OVD deliveries included were not identified in the information header files, nor was the 
reason given why the cesarean deliveries were done. If the reason for doing the 
cesarean deliveries had been failure to progress when adequate labor has not been well 
established, maternal preference, or failure to allow a trial of labor after a previous 
cesarean in appropriate patients in appropriate settings, then conservative measures per 
algorithm could have been utilized if indicated, and the patients could have been 
allowed to have a normal spontaneous vaginal delivery. This would have spared them 
having a cesarean delivery with all of the risks of major surgery that that entails. In the 
case of OVD’s the risk for the fetus is also higher, because using a vacuum extractor or 
forceps has potential for harm. 
The Clark et al.’s (2013) Algorithm for Management of Category II Fetal Heart Rate 
Tracings, algorithm decision tree and associated extensive “clarifications for use in 
algorithm,” definitively gave unambiguous direction on interpretation and intervention 
for Category II FHR tracings. In blind analyzing the 552 Chudáˇcek et al., 2014 open 
access intrapartum CTG Database FHR tracings using the above algorithm, 
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unambiguous interpretation came much more easily as the blind analyses progressed. 
Another aspect of this research effort, was the experience of how this algorithm would 
work to give structure to experienced experts to expand and reinforce their professional 
judgment. Rather than the algorithm’s structured approach getting in the way of 
professional judgment, it rather instead reinforced and added to professional 
competence and judgment by providing a set of basic ideas from which to reason in 
reaching evidence-based and reasonable sets of decisions for care and management of 
labor and delivery patients. The algorithm would give new practitioners a basis on 
which to build trustworthy professional judgment for interpretation and management 
of Category II FHR tracings, and would give a boost and reinforcement of the 
professional judgment of experienced practitioners in the same area. As this research 
effort progressed through the blind analyses per algorithm of the 552 FHR tracings, the 
task of analysis quickly became easier, as the algorithm’s logic is melded with decades 
of experience. This is not a small thing. It is easy to see the power of such a useful tool, 
as it is used over time, it becomes an expansion of skill levels, clearing up ambiguity, 
and substituting clarity. The evidence can be found in the results following Research 
Question 2. This potential should be examined more fully in clinical settings, by clinical 
practitioners in real-time, now that post-facto research is demonstrating its practicality. 
Specific Aim 2  
The second specific aim of this study was to generate more evidence regarding 
the efficacy of the Clark et al., 2013 Category II fetal heart rate tracing algorithm. 
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Research Question 2  
Can using the Clark et al.’s (2013) Algorithm for Management of Category II Fetal 
Heart Rate Tracings on the 552 fetal heart rate and uterine contraction tracings result in 
different recommendations for management and intervention forecasting a possibly 
improved outcome over the actual result? 
 Research question 2 sought to ascertain if using Clark et al.’s (2013) Algorithm for 
Management of Category II Fetal Heart Rate Tracings, algorithm decision tree and 
associated extensive “clarifications for use in algorithm,” would result in different 
recommendations for management and intervention forecasting a possibly improved 
outcome over the actual result. 
 Highly significant evidence was discovered which would potentially have 
resulted in improved outcomes over the actual results.  
 The first illustration was when the actual results, with their associated blind 
analyses were sorted by pH, and the results with pH levels below 7.20 were examined; 
it was found that all but two FHR tracings had an algorithm-driven recommendation of 
conservative intervention. The Z-Score was -18.3897. The p-value was 0. The result was 
significant at p<0.01. The proportion of responses for Observation 1 was 0.011. The 
proportion for Observation 2 was 0.989. The Fischer Exact Test statistic value was 0. The 
result was significant at p<0.01. This algorithm-driven recommendation, which if acted 
upon at the time the FHR tracings were generated, would have potentially ameliorated 
the acidemic condition of the fetuses, resulting in improved fetal status during labor, 
and upon delivery, resulting in improved overall newborn health status. This 
algorithm-driven method can also improve fetal status to the point of potentially 
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making an OVD or cesarean delivery unnecessary, and allowing a normal spontaneous 
vaginal delivery to occur with better fetal status as a result. There were seventeen 
possible examples of this in this pH levels below 7.20 group.  
 The second illustration was also when the actual results, with their associated 
blind analyses outcomes were sorted by pH, and the results with pH levels below 7.20 
were examined; it was found that all of the FHR tracings with algorithm-driven 
recommendations for earlier radical intervention (OVD or cesarean) were in this group. 
The earlier algorithm-driven radical intervention ranged from 5 minutes to 34 minutes. 
The average was 18.4 minutes. In fetuses with this status, severe metabolic acidosis can 
be ameliorated or prevented by earlier recognition and intervention. “Barring a sentinel 
event, use of this algorithm would result in birth of a severely depressed infant with 
metabolic acidosis in less than 1/5000 labors, which probably represents a technical 
threshold for visually interpreted fetal heart rate monitoring” (Clark et al., 2016). In the 
case of those fetuses identified per algorithm in blind analyzing the 552 Chudáˇcek et 
al., 2014 open access intrapartum CTG Database FHR tracings for earlier radical 
intervention, this is certainly true, as intervening even a few minutes earlier can make a 
large difference in the fetal outcome, such as when a shoulder dystocia, umbilical cord 
prolapse, uterine rupture, or significant placental abruption occur. 
 A third illustration was when the actual results, with their associated blind 
analyses outcomes were sorted by base deficit in extracellular fluid level (BDecf), all 17 
of the FHR tracings with algorithm-driven recommendations for earlier radical 
intervention (OVD or cesarean) had pH less than 7.20 and 47% (8 out of 17) had severe 
metabolic acidosis with base deficit in extracellular fluid level above 12. Indeed, the 
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algorithm was sensitive enough to identify and recommend early, conservative 
intervention to prevent fetal harm before pH fell to dangerous levels, yet did not result 
in early delivery intervention recommendations for any tracings with normal pH. 
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CHAPTER 5 
DISCUSSION 
 This section discusses the study’s findings as related to the two research 
questions, with specific considerations of limitations, significance for practice, and 
recommendations for future research. All results supported the efficacy of using the 
Clark et al., 2013 algorithm as a simple and quick means for identifying and treating 
fetuses with Category II FHR tracings to improve pH during labor and birth. The 
algorithm is particularly good in identifying fetuses with potentially low pH during 
labor, and is very helpful in assessing positive fetal responses to conservative 
interventions for suspect fetal heart rate tracings. 
Research Question 1 
 Will Clark et al.’s (2013) Algorithm for Management of Category II Fetal Heart Rate 
Tracings reliably give unambiguous direction on interpretation and intervention for 
Category II fetal heart rate tracings? 
 Comparing the blind analysis per algorithm data with the actual outcome header 
files data confirmed the interpretation and intervention efficacy of the Clark et al. 2013 
algorithm in identifying Category II FHR tracings, and giving meaningful, clear 
direction for useful intervention strategies to potentially change those tracings to 
Category I (Normal) tracings. The algorithm decision tree is easy to use and memorize, 
and the various options for moving through the tree to decide what must be done in 
reaction to the various types of tracings made sense in context. The ‘clarifications for 
use in algorithm’ are clear, and provide expert guidance, which complements and 
enhances professional judgment. The results when using the algorithm on blinded post 
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facto FHR tracings, gave a clear path for improvement over the actual outcome. In the 
final analysis, during this research effort, the algorithm has fulfilled its promise giving a 
set of techniques for correctly identifying Category II FHR tracings, and giving 
unambiguous direction for correcting the problems associated with fetuses manifesting 
those same Category II FHR tracings, potentially returning those fetuses to Category I 
status. 
Research Question 2 
 Can using the Clark et al.’s (2013) Algorithm for Management of Category II Fetal 
Heart Rate Tracings on the 552 fetal heart rate and uterine contraction tracings result in 
different recommendations for management and intervention forecasting a possibly 
improved outcome over the actual result? 
 Using the Clark et al.’s (2013) Algorithm for Management of Category II Fetal Heart 
Rate Tracings on the blind analyses of the 552 fetal heart rate and uterine contraction 
tracings in this research study, resulted in significantly different interpretation and 
intervention recommendations for management and intervention. Virtually all (98.9%) 
of the fetuses which in the actual results, had a pH below 7.20 (below normal) were 
identified previously during the blind analyses per algorithm as requiring either 
conservative (as described earlier) or radical (OVD or cesarean) intervention. This 
illustrates the sensitivity of the algorithm-based method. With this level of sensitivity, 
most fetuses manifesting a low pH and other associated problems, may be identified, 
and proper intervention applied to improve the situation, and potentially return the 
fetus to normal, healthy status.  
 
 79 
Limitations 
 There are several limitations to this study. Only one publicly available database 
exists of the size needed for this research. While this database restricted the size and 
variety of populations that were studied, it also validates the worthiness of publishing 
future large(r) datasets, especially including FHR tracings from populations with 
significant neonatal morbidities that might be attributable to health care management 
during the intrapartum period. 
 The database was produced using exclusion criteria by Chudáˇcek et al. 
(2014) to reduce the number of tracings from 14,492 to 552 before being uploaded for 
availability in the open access intrapartum CTG database. Some of the exclusions were: 
Exclude maternal age < 18 years, weeks of gestation - include only fetal weeks of 
gestation > 37, exclude known fetal diseases – congenital defects or intrauterine growth 
restriction etc., include type of gravidity - only singleton, uncomplicated pregnancies 
and exclude records with missing umbilical artery pH.  
Detailed information on inclusion, exclusion and other criteria are discussed in the 
Description of Data section of Chapter III. 
Following is the selection flowchart (See figure 10) used by Chudáˇcek et al. 
(2014) to reduce the number of tracings from 14,492 to 552 before being uploaded for 
availability in the open access intrapartum CTG database. 
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Figure 10: Selection Flowchart For The Final Public Database 
(Chudáˇcek et al., 2014, p. 6). Copyright 2014 by Chudáˇcek. Reprinted under 
terms of the Creative Commons Attribution License. 
 
As can be seen, many important varieties of delivery types usually seen in the 
larger population have been excluded. This flowchart illustrates the need for many 
more, larger, and varied FHR tracings databases are needed to do substantive and 
meaningful research in electronic FHR monitoring, as well as to find and substantiate 
significant new, improved ways to interpret and intervene on the basis of electronic 
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FHR monitoring results. 
 A second, and important limitation to this study, was that none of the 552 
laboring mothers in the dataset had any narcotic or synthetic narcotics during the fetal 
heart rate recordings. As such, the results may be generalizable only to non-
systemically medicated birthing populations. Of the 16 women with preeclampsia, 4 of 
their babies were born with a pH <7.20, and there was no information given if maternal 
magnesium sulfate or other medications that might affect FHR were administered. 
 The third important limitation to this study is the possible inaccuracy of the pH, 
base excess, and base deficit in extracellular fluid results in the data. It was not specified 
if all umbilical artery sampling for blood gases was performed within a specified time, 
was from double clamped umbilical cord segments vs. from unclamped umbilical cords 
or from placental arteries, etc. Both pH and base excess results from non-clamped cords, 
or from placenta, will significantly exponentially decrease if drawn at 30, 60, and 90 
minutes after delivery (Mokarami, Wiberg, & Olofsson, 2013). Also, possible lab, 
transcription, or inadvertent umbilical vein instead of artery sampling errors may occur, 
and even samples drawn immediately or from double clamped cord segments will give 
inaccurate results if contaminated with ambient air (Pomerance, 2004).  
 Last, while FHR and uterine pressure signal loss complicated to varying degrees 
analyzing 123 of the 177 tracings where pH was less than 7.20, the signal loss was 
comparable to that in many U.S. settings. Some of the more challenging analyses 
occurred where uterine contraction monitoring had been discontinued at the start of or 
during second stage, a problem that still occurs in too many U.S. hospitals.  
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Significance for Practice 
 Because nurses and physicians make ongoing labor management decisions both 
independently and jointly for each patient, it is important to have a common 
understanding and set of parameters guiding assessment, intervention, and 
communication for early recognition and appropriate management of Category II and 
Category II fetal heart rate tracings. This study has provided more evidence that the 
Clark et al. (2013) algorithm decision tree and associated extensive “clarifications for use 
in algorithm with Category II FHR tracings does give unambiguous direction on 
interpretation and intervention based upon the secondary analyses of these 552 fetal 
heart rate tracings. The results showed that a significant proportion >98.8% (n=175) of 
different recommendations for management and conservative, non-operative 
intervention for the 177 FHR tracings where abnormal pH <7.20. There was an average 
earlier delivery recommendation of 18.4 minutes (range 5 to 34 minutes) per algorithm 
for 17 of the 552 tracings, all of which had pH <7.20 (range 6.85 to 7.18), forecasting a 
probable improved outcome over the actual result. 
 The longest FHR tracing used in this study was 90 minutes of recording. There 
were no Category III tracings found. Review for Category I FHR tracings took on 
average, less than five minutes. Up to 30 minutes was required to analyze each of the 
more complicated Category II FHR tracings, especially when significant sections had 
missing or poor signal recording, or when patient history and prior parts of the tracing 
would have certainly added clarity and greatly decreased review time required. This is 
very important, since ease of application was very reasonable for using the Clark et al. 
(2013) algorithm decision tree and associated extensive “clarifications for use in 
 83 
algorithm with Category II FHR tracings”. The value of an easy-to-use algorithm for 
assessing and managing Category II FHR tracings is key to successful evaluation, 
recommendation, and standardization for adoption in the obstetrical setting. 
 The speed and extent to which general adoption will occur, in the U.S., of the 
Clark et al. (2013) algorithm decision tree and associated extensive clarifications for use 
in algorithm with Category II FHR tracings, will likely depend on several factors. The 
most important is more and varied research, using larger and more variegated 
databases, and also its use in many different clinical situations, by many different 
clinicians. 
Future Research 
 There is a current need for open-access databases of electronic fetal heart rate 
tracings with associated newborn outcome data from at least five different populations 
of maternal-fetal groups within the United States. This would provide resources to 
collect and work with the needed electronic fetal heart rate tracings and associated data 
from multiple birthing hospitals in the United States. It would be the first open-access 
database of U.S. fetal heart rate tracings for research purposes. This would give 
researchers opportunities to use relatively large commonly shared databases of fetal 
heart rate tracings from fetuses with normal outcomes, adverse outcomes, and from 
preterm, term, drug or condition specific exposed fetuses, induced vs. spontaneous 
labors, etc. At the present time, it is very difficult to gather population-specific 
electronic fetal heart rate tracings in sufficient numbers and with standardized data to 
allow for successful comparative research. 
 
 84 
Summary 
 This study has helped validate, for possible universal adoption, a relatively 
uncomplicated yet very specific algorithm. The algorithm was created by eighteen 
renowned obstetrical leaders, from medicine, nursing, and nurse-midwifery. It 
specifically addresses the most challenging issue in electronic fetal monitoring - the 
gray areas of indeterminate fetal heart rate tracings known as Category II fetal heart 
rate tracings, which occur with varying attributes, severity, and duration with most 
fetuses during the labor/delivery process. A huge need exists for a nationally 
recognized, unambiguous electronic fetal heart rate interpretation and management 
standard for intrapartum care in the United States. 
 The speed and extent to which general adoption will occur, in the U.S., of the 
Clark et al. (2013) algorithm decision tree and associated extensive clarifications for use 
in algorithm with Category II FHR tracings, will likely depend on several factors. This 
Category II FHR tracing unambiguous interpretation, decision and intervention 
algorithm has a growing group of people behind it, and it looks like an answer to a 
large problem in maternal/fetal labor management.  This innovation adoption 
movement is being initiated by healthcare researchers doing studies, and practitioners 
doing personal testing, utilizing the Category II FHR tracing unambiguous 
interpretation, decision, and intervention algorithm in practice situations at hospitals 
and birthing centers to test the efficacy of the technique in many varied real-world 
situations. This process of early adopters personally professionally testing a new 
technique, machine, or prescription drug is typically how the diffusion of innovation 
adoption process begins and spreads in the healthcare world. Testing by various 
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authorities such as government entities and corporations is not enough to convince 
physicians and nurses to wholesale adopt a new technique. The new technique must be 
tested, tried, and accepted by the leading practitioners in each area of the country. Then 
the process of diffusion of the new and innovative technique can expand, as the early 
adopters, who have thoroughly tested the new technique and are satisfied that it 
performs up to their personal standards, spread the news of the new innovation to their 
peers. These peers then test the technique themselves, and if it measures up to their 
expectations, they then spread it to their peers, and so on, until the “tipping point” is 
reached, and the innovation spreads with almost geometrical speed throughout the 
population of possible users (Rogers, 2003).  
Given the closely-knit connectivity of the healthcare world, the acceleration of 
this diffusion of a new healthcare innovation can be breath-taking in its speed of 
adoption, if the innovation is of such a nature as to solve a serious problem in an 
efficiently thorough and successful fashion, such as the Category II FHR tracing 
unambiguous decision and intervention algorithm seems to be; and if it is promoted 
properly through interpersonal diffusion channels. The power of interpersonally 
communicated positive experience through near peers cannot be underestimated. 
Human beings value the personal experience acquired information related to them by 
valued friends and colleagues over that of information related to them by entities who 
are distant and seen as less able to relay their information in a fashion palatable to 
healthcare practitioners in particular and is seen as a less personal set of practice 
parameters. Necessarily, information relayed to them by people practicing in areas and 
situations similar to themselves, whom they respect as local leaders in their field, is 
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much more likely to have the respect of, and is more likely to be listened to with close 
interest, if the earlier adopters are enthusiastic about a new healthcare innovation they 
have personally tested. 
This Category II FHR tracing unambiguous interpretation, decision, and 
intervention algorithm also has the advantage of being a significant improvement of an 
already accepted innovation, that of electronic fetal monitoring. Because of the higher 
perceived relative advantage of the improvement, both electronic fetal monitoring and 
the Category II FHR tracing unambiguous interpretation, decision, and intervention 
algorithm assist each other in driving symbiotic validation and verification of mutual 
usefulness. With the addition of this innovative Category II interpretation and 
intervention algorithm, electronic fetal monitoring suddenly gains traction as a 
technology and technique, which can positively influence labor outcomes in a number 
of significant ways, including decreasing the cesarean rates, and lessening the severity 
and rate of less-than-optimal births. The final and most significant point to take away 
from this research effort, is that the Clark et al. (2013) Category II FHR tracing 
algorithm, the interpretation and intervention decision tree, the ten main ‘clarifications 
for use in algorithm’, and the additional sixteen clarifications, together form a toolset 
which is uniquely capable of detecting fetuses with low pH below 7.20, and providing 
direction for interventions to return the fetuses to normal pH levels and recover 
Category I (Normal) status, thus potentially putting them on the path to a normal, 
spontaneous vaginal delivery. 
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APPENDIX 
Intrapartum management of category II fetal heart rate 
tracings: towards standardization of care 
Steven L. Clark, MD; Michael P. Nageotte, MD; Thomas J. Garite, MD; Roger K. Freeman, MD; David A. Miller, 
MD; Kathleen R. Simpson, RN, PhD; Michael A. Belfort, MD, PhD; Gary A. Dildy, MD; Julian T. Parer, MD; 
Richard L. Berkowitz, MD; Mary D’Alton, MD; Dwight J. Rouse, MD; Larry C. Gilstrap, MD; Anthony M. 
Vintzileos, MD; J. Peter van Dorsten, MD; Frank H. Boehm, MD; Lisa A. Miller, CNM, JD; Gary D. V. Hankins, 
MD 
I nterpretation and management of fetal 
heart rate (FHR) patterns during labor 
remains one of the most problematic issues 
in obstetrics. Multiple basic science 
investigations and clinical trials have been 
published since the introduction of this 
technique in the late 
1950s.1-7 Unfortunately, this body of work 
has primarily served to raise more questions 
than it has answered-as a medical 
community, we seem to know less than we 
thought we did 30 years ago regarding the 
utility of this ubiquitous technique. 
In recent years, several specific issues 
 relating to the interpretation and 
management of FHR patterns have received 
considerable attention in the medical 
literature. These include the lack of 
agreement in interpretation even among 
recognized experts, the role of FHR patterns 
as a primary driver of a rising cesarean rate, 
and the explosion of litigation involving FHR 
patterns, despite the consistent absence of 
scientific evidence to support the contention 
that intervention based on any single 
FHR pattern or combination of FHR patterns 
in fact prevents cerebral palsy or other types 
of neurologic impairment.8-12 Against this 
background, however, there remains in many 
of us suspicion (albeit based primarily upon 
anecdotal experience and the original basic 
science investigations) that at least a portion 
of the conflicting evidence regarding the 
clinical utility of intrapartum FHR 
monitoring results from ad hoc interpretation 
of terminology, and the lack of standardized 
protocols for management and intervention 
based on what are often challenging patterns. 
In a very real sense, the FHR monitor is a 
medical device that was introduced into  
There is currently no standard national approach to the management of 
category II fetal heart rate (FHR) patterns, yet such patterns occur in the 
majority of fetuses in labor. Under such circumstances, it would be difficult 
to demonstrate the clinical efficacy of FHR monitoring even if this 
technique had immense intrinsic value, since there has never been a standard 
hypothesis to test dealing with interpretation and management of these 
abnormal patterns. We present an algorithm for the management of category 
II FHR patterns that reflects a synthesis of available evidence and current 
scientific thought. Use of this algorithm represents one way for the clinician 
to comply with the standard of care, and may enhance our overall ability to 
define the benefits of intrapartum FHR monitoring. 
Key words: fetal heart rate monitoring, neonatal encephalopathy, patient 
safety 
 
clinical practice without an instruction manual, without the now common 
premarket testing to support the unrealistic expectations of efficacy, and 
without clearly defined parameters for use. Under such circumstances, it 
would be difficult to demonstrate clinical efficacy even of a device with 
immense intrinsic value, since there has never been a standard hypothesis 
to test dealing with interpretation and management of abnormal patterns. 
With respect to the assessment of the clinical value of FHR monitoring, an 
evolving consensus exists in the maternal-fetal medicine community that it 
is time to start over and establish some common language, standard 
interpretation, and reasonable management principles and guidelines.13-19 A 
Eunice Kennedy Shriver National Institute of Child Health and Human 
Development (NICHD) consensus panel in 2008 proposed a uniform 
system of terminology in which any FHR pattern is classified as category I, 
II, or III, based on the presence or absence of well-defined aspects of the 
FHR.20 Once universally adopted in clinical practice, these definitions 
should serve as an important first step in both the investigation of the 
significance of various FHR patterns, and the development of a uniform 
standard of care in the interpretation and management of such patterns. 
With this in mind, subsequent recommendations have been developed by 
the American Congress of Obstetricians and Gynecologists (ACOG) for the 
management of category I (normal) and category III (pathologically 
abnormal) FHR patterns.20,21  Although useful, these recommendations 
remain insufficient since _ 80% of fetuses in labor demonstrate FHR 
patterns that fall into category II, patterns for which no specific ACOG 
management recommendations exist.21,22 
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The management of category II FHR patterns 
remains the most important and challenging issue 
in the field of FHR monitoring, and is arguably 
second only to preterm birth as the most pressing 
issue in clinical obstetrics. In addition, the overall 
cesarean delivery rate exceeded 32% in the United 
States in 2011, and exceeds 50% of all births in 
some US hospitals.23 While dystocia and prior 
cesarean delivery remain the leading indicators for 
such surgical intervention, the presence of a 
category II or III FHR in labor is a frequent 
indication as well.11,24  For cesarean deliveries, 
there is a wide variance in the reported indications 
and their frequency, both between hospitals and 
among members of the medical staff practicing 
obstetrics.24.  Concern regarding FHR patterns is 
perhaps the indication that has the greatest such 
variance; we believe this observation is directly 
related to the absence of defined management 
protocols for category II patterns. 
Accordingly, we present a suggested algorithm for 
the management of category II FHR patterns 
(Figure 1) along with several important specific 
clarifications (Table). As outlined in 
Figure 1, it is reasonable to initiate management of 
a category II FHR pattern with an assessment of 
variability and accelerations, thus allowing the 
clinician to immediately rule out the presence of 
clinically significant metabolic acidemia. For 
nonacidemic fetuses, the focus then shifts to 
assessing the likelihood of developing significant 
acidemia prior to delivery. While no algorithm can 
predict all cases of sudden deterioration due to 
sentinel events, even with category I FHR patterns, 
analysis of the frequency and nature of 
decelerations and the progress in labor provides the 
clinician with a reasonable approach to such 
decision making (Figure 1). With category II FHR 
tracings that do not exhibit moderate variability or 
accelerations, but do exhibit patterns of persistent 
late or significant variable decelerations, as defined 
in the Table, significant metabolic acidemia cannot 
be excluded. Further, these deceleration patterns 
signify the presence of physiologic stresses that 
increase the risk of developing such acidemia. In 
such cases, we recommend expeditious delivery. 
Examples of the application of this algorithm are 
demonstrated in Figures 2-5. These examples 
assume that the 20-minute period shown in the 
figures is representative of the 30-60 minute 
observation period referred to in the algorithm. 
Should the pattern either improve or deteriorate 
during this time frame, management should be 
changed accordingly. 
In assessing and implementing this algorithm, we wish 
to bring specific attention to a number of considerations 
which we consider to be particularly germane. 
1. This algorithm follows the foundational 
NICHD definitions and recommendations.20,21 
 2. This algorithm should be understood as a next step 
in the development of management recommendations 
for category II FHR patterns. The effectiveness and 
associated intervention rates of this algorithm may be 
further defined and refined in future studies. 
3. Category II patterns identify fetuses that may 
potentially be in some degree of jeopardy but are either 
not acidemic, or have not yet developed a degree of 
hypoxia/acidemia that would result in neonatal 
encephalopathy.12,20,21  However, we believe one 
important goal of intrapartum care is delivery of the 
fetus, when possible, prior to  the development of 
damaging degrees of hypoxia/acidemia. 
We offer this algorithm to assist the attending physician 
in accomplishing this goal. We recognize that 
adherence to the algorithm cannot alter the course for 
an already injured fetus, or one that experiences an 
unexpected catastrophic event during labor. 
However, since any algorithm for the management of 
category II patterns will apply to the majority of fetuses 
during labor, the algorithm must also avoid unnecessary 
intervention, and encourage vaginal delivery in women 
whose 
FHR patterns suggest minimal risk of significant 
deterioration prior to delivery. We designed this 
algorithm with both goals in mind, but with a primary 
focus on the avoidance of preventable injury. 
4. The appropriateness of select conservative attempts 
to relieve certain category II patterns is well 
established.25-29  However, valid scientific evidence 
affirming the effectiveness of such measures varies 
widely. For example, while amnioinfusion for relief of 
oligohydramnios-associated variable decelerations is 
well supported in the literature, no evidence exists to 
support the efficacy of maternal oxygen administration 
in commonly achievable concentrations in increasing 
fetal tissue oxygenation, or in improving newborn 
outcomes regardless of oxygen concentration.28,29  
Nevertheless, any of the commonly accepted 
approaches to relief of abnormal FHR patterns may be 
appropriately attempted in specific situations. 
Their effect should be apparent within 30 minutes of 
application (Figure 1). If the FHR tracing remains 
category II following these efforts, the algorithm is 
applied to the pattern observed following these attempts 
at therapeutic intervention. 
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Attention should be given to the prompt elimination of 
excessive uterine activity including tachysystole or 
prolonged contractions, especially when uterine 
stimulants (oxytocin or prostaglandin-containing 
agents) are being applied.30,31  Oxytocin infusion 
should be reduced or discontinued in the presence of 
excessive uterine activity and a persistent category 
II FHR pattern.21  Acceptable approaches to 
monitoring of uterine activity are well described in 
available literature.30,31 
 5. Recent data suggest that no single quantitative 
value of fetal arterial pH serves to defi ne a point of 
hypoxia-induced damage applicable to all fetuses.32  
However, the literature is consistent in its 
demonstration that for any individual fetus, baseline 
variability and accelerations will reliably be depressed 
before the pH has reached a level of acidemia 
associated with neurologic injury for that fetus, 
regardless of its quantitative value.33,34  Hence this 
algorithm relies strongly on the presence of moderate 
baseline variability or accelerations. In contrast, 
conflicting data exist regarding the significance of 
variability within deceleration nadirs.35,36  Variability 
within decelerations alone cannot be reliably used to 
exclude fetal acidemia and accordingly is not 
addressed in this algorithm. 6. FHR patterns cannot be 
interpreted in isolation. Accordingly, we have 
incorporated labor progress as described in traditional 
terms (stage I latent phase, stage I active phase and 
second stage) into this algorithm. This is of 
significance since the expected remaining length of 
labor may influence the likelihood of, and response to, 
deterioration of category II patterns. A category II 
pattern may have a different indicated management 
when presenting in early first-stage labor than an 
identical pattern presenting in the late second stage. 
We acknowledge recent data suggesting that cesarean 
delivery based on classic definitions of protracted 
active phase, arrest of dilatation, or arrest of second-
stage descent alone may not be necessary, and that 
longer periods of observation may yield lower 
intervention rates.10,37  However, data demonstrating 
the safety of these more conservative approaches in 
the presence of persistent category II 
FHR patterns are lacking. For example, we hesitate to 
recommend nonintervention for an arrest of active 
phase dilatation of 4 hours in the presence of recurrent 
late decelerations, even in the presence of moderate 
variability. The superb reliability of accelerations and 
moderate variability in excluding any degree of 
hypoxia-related central nervous system depression or 
risk of ongoing hypoxic injury would allow 
observation of patterns with these features and 
adequate labor progress regardless of the deceleration 
pattern (Figure 1). 
However, intervention in patients with certain category II 
patterns and slow, but technically adequate labor 
progression may also be an appropriate option. 
7. Some well-defined features of category II patterns (eg, 
fetal tachycardia or marked variability) are not included 
in the algorithm based decision tree for intervention. 
This does not signify that such patterns are innocuous 
indeed, it may be exactly these features of a tracing that 
mandate consideration as a category II pattern, and the 
use of this algorithm. However, in such cases, it is our 
expectation that other concerning patterns included in the 
algorithm will appear prior to the need for intervention. 
8. This algorithm is intended to address the challenge of 
progressive intrapartum hypoxia/acidemia due to the 
effects of labor contractions on a susceptible fetus. 
Neither this, nor any other management approach to 
labor, will ever predict, or prevent, unexpected sentinel 
events that may occur without warning and rapidly 
change a FHR pattern from category II to category 
III. In such situations, even the most expeditious 
response may be insufficient to avoid neonatal 
encephalopathy and its sequelae.38,39 
 However, 2 clinical situations exist in which category II 
patterns, while excluding ongoing hypoxia/acidemia, 
may be harbingers of sentinel events that may rapidly 
lead to profound hypoxia. These conditions are vaginal 
bleeding sufficient to suggest possible placental 
abruption, and any woman undergoing a trial of labor 
after a previous cesarean.40-42  In both cases, this 
algorithm does not apply, as expeditious cesarean 
delivery is often indicated based on the sudden 
appearance of decelerations in a context (moderate 
variability and accelerations) that would be otherwise 
reassuring. 
9. This algorithm does not address the issue of prolonged 
deceleration, as defined by the NICHD. This definition is 
too broad to be clinically useful in isolation.20,21  A 121- 
second deceleration to 90 beats/min and a 9-minute and 
59-second deceleration to 50 beats/min are, from a 
clinical standpoint, very different, yet both are, by 
definition, prolonged decelerations. The situations 
associated with prolonged decelerations also greatly 
impact the decision making - a prolonged deceleration 
following an epidural should give rise to a completely 
different set of management considerations than an 
identical pattern in a woman laboring with a scarred 
uterus.40,42,43  Such variations are legion and cannot be 
adequately addressed with a single algorithm - indeed, 
their rarity and physiologic heterogeneity probably 
preclude meaningful study as a group. We can only 
comment that tolerance for such recurrent patterns 
remote from delivery ought to be small unless the 
etiology is apparent and can be promptly ameliorated. 
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10. The current NICHD classification system uses the 
classic descriptions of deceleration patterns initially 
developed by Kulbi and colleagues.1 
 However, because different types of decelerations have 
unique etiologies, a given fetus may have > 1 
pathologic process ongoing during labor. One example 
would be a growth-restricted fetus with 
oligohydramnios demonstrating both variable 
decelerations secondary to cord compression and late 
decelerations due to hypoxia during contractions based 
on uteroplacental insufficiency. This may give rise to a 
less well-defined, hybrid pattern of decelerations - for 
example, late decelerations superimposed upon variable 
decelerations. Because relatively benign variable 
decelerations are visually more dramatic than the subtle, 
yet more concerning, late decelerations - the latter may 
be easily overlooked. In such cases, the patient should 
be managed with a focus on the late, rather than the 
variable decelerations. Such hybrid deceleration 
patterns differ from the more commonly seen “ 
atypical” variable decelerations that have no correlation 
with fetal acidemia.35  It is important for clinicians to 
carefully evaluate any atypical-appearing variable 
decelerations in this light. 
11. The algorithm presented authorizes judgment in 
some situations between cesarean delivery and 
operative vaginal delivery. We wish to emphasize that 
operative vaginal delivery is not universally applicable, 
but rather depends on the patient meeting appropriate 
criteria for vacuum or forceps, as well as operator 
expertise in use of these techniques.44,45  Because 
delivery based on this algorithm will be principally 
driven by concern for fetal well-being, and because 
variable levels of expertise in operative vaginal delivery 
exist among practitioners, we anticipate that cesarean 
delivery will be the most common procedure elected in 
many situations. In contrast to some types of category 
III tracings in which the urgency of intervention may 
occasionally justify acceptance of some degree of risk 
for trauma, the vast majority of category II tracings in 
which delivery is indicated only warrant initiation of 
delivery within 30 minutes of the decision for delivery. 
A limited attempt at operative vaginal delivery by an 
experienced clinician may represent optimal care in 
some circumstances. However, the physician with 
limited experience in operative vaginal delivery should 
not delay preparations for cesarean, nor persist in 
attempts at operative vaginal delivery without 
progressive descent with each contraction. 
Without real expertise in operative vaginal delivery, a 
deteriorating category II FHRT will often be best 
managed by prompt cesarean delivery. 
 
12. The most vexing issue in the development of this 
algorithm was the issue of decreased vs. absent 
variability. We accept the accuracy of data concluding 
that FHR variability must be absent to reliably reflect a 
high degree of correlation with severe fetal 
acidemia.20,21 
 However, we caution against delaying delivery of a 
deteriorating FHR pattern because criteria indicating 
probable severe metabolic acidemia have not yet been 
met. We have chosen to treat persistent minimal and 
absent variability as one for the following reasons. 
a. Variability cannot be considered to be a strictly 
binary feature of a FHR pattern. It is evident that a fetus 
with moderate variability (thus excluding concurrent 
fetal metabolic acidemia) that devolves to a state of 
frank asphyxia and severe metabolic acidemia with 
absent variability as a result of episodes of intrapartum 
hypoxia must first pass through a stage of minimal 
variability, unless the deterioration is abrupt and 
catastrophic as seen in a sentinel event. 
b. While it is possible for apparent variability to be 
exaggerated with the use of a first-generation external, 
ultrasound-based heart rate monitoring device, 
autocorrelation techniques employed with most current 
monitoring systems have minimized this tendency.46  
Unfortunately erratic signal detection or transient 
artifact may give rise to periods of apparent “ minimal 
variability”  that could be falsely reassuring to some 
clinicians and lead to delay in delivery. If technically 
feasible, the fetus with a category II pattern and poor 
FHR signal quality should be monitored with a fetal 
scalp electrode. 
c. An external FHR monitor that yields a consistent 
high-quality tracing, or a continuous fetal scalp lead 
tracing, will generally allow the qualified clinician to 
distinguish different degrees of variability, even in the 
presence of classic late or variable decelerations. 
Unfortunately, such a determination may be rendered 
more difficult by many of the category II patterns 
actually encountered in clinical practice. 
Such difficulties are especially common in the presence 
of atypical variable decelerations, in which 
determination of return to baseline may be difficult. 
In such cases, a “ baseline” apparently exhibiting some 
degree of variability may in fact still be a part of a 
recovering deceleration. With exceptional expertise, 
most of these situations can be appropriately delineated. 
However, that level of expertise is not universal among 
practicing obstetricians. Indeed, even among recognized 
experts there is significant interobserver variation in the 
differentiation of FHR patterns with minimal vs. absent 
variability.9 
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A basic principle of any safety protocol is the 
direction of such guidelines to the least, not the 
greatest expected level of user competence. 
Thus, we have used moderate rather than moderate or 
minimal variability as a defining reassuring feature of 
our algorithm. While we acknowledge that such a 
decision will lead to intervention in cases that, in 
hindsight, might be proven to be unnecessary, we 
believe that following the algorithm as written will 
avoid preventable neurologic injury due to lack of 
intervention for a category II FHR pattern, and will be 
associated with an appropriate intervention rate. Cases 
of fetal hypoxia/acidemia during labor due to 
unexpected sentinel events remain largely 
unpreventable.38,39 
 13. A fetus presenting with persistent minimal to 
absent FHR variability and absent accelerations but 
without significant decelerations poses a significant 
diagnostic and management dilemma. In many of 
these cases, such a pattern represents preexisting 
central nervous system injury with marked metabolic 
acidemia. In other cases, intrauterine events leading to 
the injury may have resolved (eg, umbilical cord 
compression) and the fetus will have recovered 
metabolically, but not neurologically. Developmental 
anomalies unrelated to hypoxia/acidemia may give 
rise to a similar picture. Although the benefit of 
cesarean delivery in improving neurologic outcome in 
such fetuses has never been demonstrated, these 
fetuses may be less likely to tolerate the additional 
hypoxia and acidemia that accompanies even normal 
labor without intrapartum demise. In the absence of 
significant decelerations however, the clinician may 
be assured that while the fetus may be damaged, it is 
not being damaged. Under these circumstances, a 
limited period of observation is appropriate, and is 
embraced in the algorithm. 
14. The algorithm presented here represents a 
consensus of the best thoughts of 18 authors regarding 
one reasonable approach to category II FHR patterns 
given our present scientific understanding. All authors 
are highly experienced clinicians with significant peer 
reviewed research experience and publications in the 
area of fetal evaluation. They also represent a broad 
geographic spectrum and experience in both the 
academic and private practice worlds and represent 
the disciplines of medicine, nursing, and midwifery. 
As such, it is reasonable for clinicians to utilize this 
algorithm in the management of category II FHR 
patterns; compliance with this protocol is one way to 
meet the standard of care in the United States. 
Importantly, as with most other areas of medicine, the 
establishment of this algorithm as one way to comply 
with the standard of care does not exclude the 
existence of other equally acceptable approaches.  
While the authors uniformly agree on the 
appropriateness of this model for any laboring patient, 
each of us can think of numerous situations in which 
alternative approaches to any branch of the algorithm 
would be equally acceptable. 
15. This algorithm is supported by available clinical 
experience, a substantial body of basic science 
evidence, and indirect clinical data. Given the current 
state of obstetric knowledge, we do not believe it is 
possible to simultaneously eliminate preventable fetal 
neurologic injury and significantly reduce the cesarean 
delivery rate for abnormal FHR patterns - several 
decades of such attempts have resulted in the current 
state of Brownian motion in which neither goal has 
been measurably achieved. Our goal in developing 
this algorithm has been to fix one variable in this 
equation by presenting an algorithm, which if 
implemented as one component of good obstetrical 
care, will assist the clinician in avoiding preventable 
intrapartum fetal hypoxia, metabolic acidemia, and 
hypoxic injury based on failure to deliver in the face 
of certain persistent category II FHR patterns. Of 
course, as with any set of recommendations, clinical 
studies directly applying this algorithm both 
retrospectively to large series of category II patterns, 
and prospectively to large populations, are needed to 
potentially improve the efficacy of the algorithm, and 
to better ascertain the actual intervention rate 
associated with its application. It is anticipated that 
such studies may facilitate refinement of this basic 
algorithm to reduce the intervention rate without 
incurring preventable morbidity or mortality. 
16. We make no claim of the superiority of this 
algorithm over other approaches that might have been 
developed. We began with the premise that 
standardization and simplification of critical care 
processes are fundamental principles of patient safety. 
In virtually any human endeavor, particularly one that 
relies on the performance of multiple team members 
in an effort to achieve an optimal result, 
standardization will yield improved results. 47-50  As 
such, unless one ideal approach to care has been 
demonstrated to be superior to all others by virtue of 
well-performed clinical trials, it is not necessary to 
demonstrate the superiority of one specific approach 
over others that are, when considered individually, 
likely to be equivalent. Rather, the adoption by the 
clinical care team of one appropriate specific 
management plan will, by virtue of standardization 
alone, yield results superior to those achieved by 
random application of several individually equivalent 
approaches. This is particularly true at the facility 
level.47-50 
 For example, protocols used to guide the provision of 
cardiopulmonary resuscitation have not been 
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demonstrated to be superior to all others in randomized clinical trials.51  Yet 
the near universal adoption of these standard approaches has resulted in 
improved outcomes for cardiac arrest patients. Such algorithms have, over 
time, also undergone modification due to advances in clinical understanding 
based on new data. It is also important to note that in this instance, our 
algorithm does not seek to replace any established methodical approach to 
the management of category II patterns. Rather, we suggest that this 
algorithm will be helpful in the current clinical setting in the United States in 
which a lack of clear direction has led to divergent decision making 
regarding cesarean section for FHR abnormalities.24 
 Adoption of this algorithm for the management of category II FHR patterns 
by the clinician is one approach to achieving compliance with the current 
standard of care. Application of the algorithm, along with the integration of 
future evidence-based modifications driven by additional research, will 
provide clinicians with a standardized, simple, rational, evidence-based, and 
nationally accepted approach to the management of category II FHR 
patterns. 
 
Figure 11: Clark, et al. (2013). Algorithm for Management of Category 
II Fetal Heart Rate Tracings. Copyright 2013 by Elsevier. Reprinted with 
permission. 
 
a
That have not resolved with appropriate conservative corrective measures, which may include supplemental oxygen, maternal position changes, 
intravenous fluid administration, correction of hypotension, reduction or discontinuation of uterine stimulation, administration of uterine relaxant, 
amnioinfusion, and/or changes in second stage breathing and pushing techniques. 
Clark. Category II FHRT. Am J Obstet Gynecol 2013. Copyright 2013 by Elsevier. Reprinted with permission. 
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Table 9: Clarifications for Use in Algorithm. Copyright 2013 by Elsevier. Reprinted with 
permission. 
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GLOSSARY OF TERMS 
 
Acidemia: Low pH of the blood. May be due to continuing low oxygen levels 
preventing normal aerobic metabolism with anaerobic metabolism unable to completely 
break down glucose and instead producing the anaerobic metabolic byproduct of lactic 
acid. Lactic acid build-up may result in tissue damage to the nervous system and to 
other tissues, and if severe, may cause permanent brain damage or possibly death. 
 
Amnioinfusion: Infusion of normal saline or lactated Ringer’s solution into the uterus 
through the cervical opening after rupture of membranes to increase intra-amniotic 
fluid to cushion the umbilical cord during labor when cord compression causes variable 
FHR decelerations to occur. 
 
Augmentation of labor: Administration of a uterotonic agent, such as oxytocin, during 
the course of an already established labor to stimulate the uterus to contract more 
vigorously. 
 
Apgar score: A measure of the physical condition of a newborn infant usually 
performed at 1 and at 5 minutes of life. It is obtained by adding points (2, 1, or 0) for 
heart rate, respiratory effort, muscle tone, response to stimulation, and skin color; scores 
≥7 are normal. 
 
Avalon FM40 and FM50 Fetal Monitor: A standard fetal monitors made by Phillips 
Healthcare, USA. 
 
BDecf: base deficit calculated from the whole extracellular fluid, which will not be as 
affected by high CO2 levels as measured from blood (BDblood). Critical neonatal 
umbilical artery BDecf  > 10-12 mmol (normal 4-7 mmol/L). 
 
BE: Base excess. Critical neonatal umbilical artery bases excess > -12 mEq/L. 
 
BPM: Beats per minute. 
 
Breech presentation: Fetal presentation in which the buttocks or lower extremities are 
located in or over the maternal pelvis. 
 
Category I fetal heart rate patterns: Normal - the fetal heart rate tracing shows ALL of 
the following: 
Baseline FHR 110-160 BPM, moderate FHR variability, accelerations may be present or 
absent, no late or variable decelerations, may have early decelerations. 
Strongly predictive of normal acid-base status at the time of observation. Routine care. 
 
Category II fetal heart rate patterns: Indeterminate - the fetal heart rate tracing 
shows ANY of the following: tachycardia, bradycardia without absent variability, 
minimal variability, absent variability without recurrent decelerations, marked 
variability, absence of accelerations after stimulation, recurrent variable decelerations 
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with minimal or moderate variability, prolonged deceleration > 2minute but less than 
10 minutes, recurrent late decelerations with moderate variability, variable 
decelerations with other characteristics such as slow return to baseline, and "overshoot". 
Not predictive of abnormal fetal acid-base status, but requires continued surveillance 
and reevaluation. 
 
Category III fetal heart rate patterns: Abnormal. the fetal heart rate tracing 
shows EITHER of the following: Sinusoidal pattern OR absent variability with recurrent 
late decelerations, recurrent variable decelerations, or bradycardia. 
Predictive of abnormal fetal-acid base status at the time of observation. Depending on 
the clinical situation, efforts to expeditiously resolve the underlying cause of the 
abnormal fetal heart rate pattern should be made. 
 
Cephalic presentation: Head-first fetal presentation. 
 
Cephalopelvic disproportion: A mismatch between the dimensions of the presenting 
part and the capacity of the pelvis. 
 
CTG: Cardiotocography (CTG) is a technical means of recording the fetal heartbeat and 
the uterine contractions during pregnancy. The machine used to perform the 
monitoring is called a cardiotocograph, more commonly known as an electronic fetal 
monitor (EFM) 
 
Dystocia: Difficult labor or abnormally slow progress of labor. Other terms that are 
often used interchangeably with dystocia are dysfunctional labor, failure to progress 
(lack of progressive cervical dilatation or lack of fetal descent), and cephalopelvic 
disproportion (CPD). 
 
Early fetal heart rate deceleration: Gradual decrease in FHR with onset of deceleration 
to nadir >30 seconds. The nadir occurs with the peak of a contraction. They are due to a 
vagal response from fetal head compression and considered benign. 
 
EFM: Electronic fetal monitor 
 
EFHRM: Electronic fetal heart rate monitor 
 
Episodic fetal heart rate patterns: Those not associated with maternal uterine 
contractions 
 
Fetal heart rate baseline variability: Visual fluctuations in the fetal heart rate, termed 
as absent (undiscernable to the eye), minimal (discernable up to 5 beats per minute peak 
to trough), moderate (6-25 beats per minute/normal), or marked (>25 beats per minute) 
 
Fetal heart rate acceleration: An abrupt increase in FHR above baseline with onset to 
peak of the acceleration less than < 30 seconds and less than 2 minutes in duration. The 
peak of acceleration must be at least 15 bpm above the baseline and last at least 15 
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seconds. An acceleration lasting ≥2 minutes but < 10 minutes is a prolonged 
acceleration. Longer than 10 minutes would constitute a baseline rate change. Before 32 
weeks of gestation accelerations are defined as having a peak ≥10 bpm and a duration 
of ≥10 seconds. 
  
FHR: Fetal heart rate 
 
Gestation: Term gestation is 40 weeks, < 38 weeks preterm, >42 weeks is post-term 
 
Gravity/Gravida: Total number of times a woman has been pregnant 
 
HIE: Hypoxic Ischemic Encephalopathy (HIE) is a type of hypoxic brain damage 
 
Hypoxia: Deficiency of oxygen in the tissues 
 
Hypoxemia: A low concentration of oxygen in the blood 
 
Intrapartum: The period from the onset of labor to the end of the third stage of labor 
 
Late fetal heart rate deceleration: gradual decrease in FHR with onset of deceleration to 
nadir >30 seconds. Onset of the deceleration occurs after the beginning of the 
contraction, and the nadir of the contraction occurs after the peak of the contraction. 
They are due to uteroplacental insufficiency / lack of enough oxygen to the fetus. 
 
Liq. Praecox: Premature rupture of the amniotic sac 
 
Meconium: Fetal or neonatal bowel movement / stool 
 
Nadir: Lowest point 
 
NICU: Neonatal intensive care unit 
 
NSVD: Normal spontaneous vaginal delivery 
 
Operative Vaginal Delivery (OVD): Vacuum extractor or forceps assisted vaginal 
delivery 
 
pCO2 (kPa): Normal newborn umbilical artery pCO2 (kPa) 5.4-8 
 
Parity/Para: The number of births that a woman has had after 20 weeks gestation 
 
Periodic fetal heart rate patterns: Those associated with maternal uterine contractions 
 
pH: Critical neonatal umbilical artery pH < 7.0 
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Preeclampsia: Perinatal disorder usually involving maternal hypertension, may be mild 
or severe enough to cause fetal and/or maternal harm or death 
 
Prolonged fetal heart rate deceleration: A decrease in FHR of > 15 beats per minute 
measured from the most recently determined baseline rate. The deceleration lasts >= 2 
minutes but less than 10 minutes 
 
Pyrexia:  Temperature greater than 37.5 °C (99. 5 °F) 
 
Recurrent fetal heart rate decelerations: Occurring with 50% or more of uterine 
contractions in a 20 minute tracing 
 
Significant fetal heart rate decelerations: Are defined by Clark et al. (2013) as any of 
the following: 
•Variable decelerations lasting longer than 60 seconds and reaching a nadir more than 
60 bpm below baseline. 
• Variable decelerations lasting longer than 60 seconds and reaching a nadir less than 
60 bpm regardless of the baseline. 
• Any late decelerations of any depth. 
• Any prolonged deceleration (algorithm use should be discontinued until prolonged 
deceleration is resolved) 
 
STAN fetal monitors: Made by Neoventa in Sweden, FDA approved in the USA, is 
used in addition to a standard electronic fetal monitor, giving additional information on 
elevations and depressions of the S-T segment of the fetal EKG that suggests anaerobic 
metabolism in the fetus, and thus hypoxemia. This technology is used in a few U.S. 
hospitals currently. 
 
Stage 1 labor: From 0 cm until 10 cm cervical dilation in labor 
 
Stage 2 labor: From 10 cm cervical dilation until birth of the baby (maternal pushing) 
 
SVD: Spontaneous vaginal delivery 
 
Tachysystole: Uterine contractions occurring more frequently than 5 in a ten minute 
period 
 
Umbilical cord prolapse: If the fetal umbilical cord slips down into the vagina ahead of 
the presenting fetal part, or becomes trapped and compressed between the fetal 
presenting part and the incompletely dilated uterine cervix, pressure on the umbilical 
cord can stop blood and oxygen flow from the placenta to the fetus and may result in 
fetal harm unless the pressure on the cord is relieved or the fetus is quickly delivered. 
 
Variable fetal heart rate deceleration: Abrupt  decrease in FHR of > 15 beats per 
minute measured from the most recently determined baseline rate.  The onset of 
deceleration to nadir is less than 30 seconds. The deceleration lasts   > 15 seconds and 
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less than 2 minutes. A shoulder, if present, is not included as part of the deceleration. 
Usually due to umbilical cord compression. 
 
Vasa previa: A defect where fetal blood vessels, which normally are protected within 
the umbilical cord and placenta, instead run between the amniotic membranes as they 
enter the umbilical cord from the placenta or if the placenta has an accessory lobe with 
these unprotected fetal blood vessels. If the unprotected fetal blood vessels are over or 
near the cervix and the amniotic membranes rupture, fetal hemorrhage may ensue.  
 
Vertex: crown or top of the head. A vertex presentation is the most common and most 
uncomplicated fetal presentation during labor, whereby the fetal head is flexed and the 
occiput (back part of the head) is the leading fetal part into the vagina. 
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